<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32269505</article-id>
<article-id pub-id-type="pmc">7109447</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2020.00194</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Suzuki</surname>
<given-names>Naoki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/858467/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akiyama</surname>
<given-names>Tetsuya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/863410/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Warita</surname>
<given-names>Hitoshi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/901144/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aoki</surname>
<given-names>Masashi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c002">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurology, Tohoku University School of Medicine</institution>, <addr-line>Sendai</addr-line>, <country>Japan</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neurology, Shodo-kai Southern Tohoku General Hospital</institution>, <addr-line>Miyagi</addr-line>, <country>Japan</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Manoj Kumar Jaiswal, Icahn School of Medicine at Mount Sinai, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Philip Van Damme, KU Leuven, Belgium; Ludo M. Van Den Bosch, KU Leuven, Belgium; Masahisa Katsuno, Nagoya University Hospital, Japan</p>
</fn>
<corresp id="c001">*Correspondence: Naoki Suzuki, <email>naoki@med.tohoku.ac.jp</email></corresp>
<corresp id="c002">Masashi Aoki, <email>aokim@med.tohoku.ac.jp</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>14</volume>
<elocation-id>194</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Suzuki, Akiyama, Warita and Aoki.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Suzuki, Akiyama, Warita and Aoki</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Amyotrophic lateral sclerosis (ALS) is an intractable adult-onset neurodegenerative disease that leads to the loss of upper and lower motor neurons (MNs). The long axons of MNs become damaged during the early stages of ALS. Genetic and pathological analyses of ALS patients have revealed dysfunction in the MN axon homeostasis. However, the molecular pathomechanism for the degeneration of axons in ALS has not been fully elucidated. This review provides an overview of the proposed axonal pathomechanisms in ALS, including those involving the neuronal cytoskeleton, cargo transport within axons, axonal energy supply, clearance of junk protein, neuromuscular junctions (NMJs), and aberrant axonal branching. To improve understanding of the global changes in axons, the review summarizes omics analyses of the axonal compartments of neurons <italic>in vitro</italic> and <italic>in vivo</italic>, including a motor nerve organoid approach that utilizes microfluidic devices developed by this research group. The review also discusses the relevance of intra-axonal transcription factors frequently identified in these omics analyses. Local axonal translation and the relationship among these pathomechanisms should be pursued further. The development of novel strategies to analyze axon fractions provides a new approach to establishing a detailed understanding of resilience of long MN and MN pathology in ALS.</p>
</abstract>
<kwd-group>
<kwd>amyotrophic lateral sclerosis (ALS)</kwd>
<kwd>omics analysis</kwd>
<kwd>axonal dysfunction</kwd>
<kwd>local translation</kwd>
<kwd>axon branching</kwd>
<kwd>motor nerve organoid</kwd>
<kwd>human induced pluripotent stem cell (hiPSC)-derived motor neuron</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="235"></ref-count>
<page-count count="19"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Amyotrophic lateral sclerosis (ALS) is a devastating adult-onset neurodegenerative disorder (<xref ref-type="bibr" rid="B28">Brown and Al-Chalabi, 2017</xref>). Both the upper and lower motor neurons (MNs) are affected, such that the disorder is characterized by muscle weakness with spasticity and atrophy. Approximately 10% of ALS occurrence is familial (<xref ref-type="bibr" rid="B66">Ghasemi and Brown, 2018</xref>). Since the identification in 1993 (<xref ref-type="bibr" rid="B171">Rosen et al., 1993</xref>) of <italic>copper/zinc superoxide dismutase 1</italic> (<italic>SOD1</italic>) in ALS patients with an autosomal dominant trait in 1993 (<xref ref-type="bibr" rid="B8">Aoki et al., 1993</xref>), more than 25 genes have been reported as causative genes of familial ALS (<xref ref-type="bibr" rid="B121">Maday et al., 2014</xref>; <xref ref-type="bibr" rid="B45">De Vos and Hafezparast, 2017</xref>; <xref ref-type="bibr" rid="B66">Ghasemi and Brown, 2018</xref>; <xref ref-type="bibr" rid="B38">Cook and Petrucelli, 2019</xref>).</p>
<p>The pathomechanisms of ALS have been examined using familial ALS models. Intracellular generation of reactive oxygen species production (<xref ref-type="bibr" rid="B22">Borchelt et al., 1994</xref>; <xref ref-type="bibr" rid="B217">Wiedau-Pazos et al., 1996</xref>; <xref ref-type="bibr" rid="B81">Howland et al., 2002</xref>) and unfolded protein response/endoplasmic reticulum (ER) stress (<xref ref-type="bibr" rid="B101">Kikuchi et al., 2006</xref>; <xref ref-type="bibr" rid="B100">Kieran et al., 2007</xref>; <xref ref-type="bibr" rid="B205">Urushitani et al., 2008</xref>) have been inferred from the discovery of SOD1 as a factor. A cell non-autonomous effect (<xref ref-type="bibr" rid="B20">Boillee et al., 2006</xref>; <xref ref-type="bibr" rid="B49">Di Giorgio et al., 2007</xref>; <xref ref-type="bibr" rid="B141">Nagai et al., 2007</xref>; <xref ref-type="bibr" rid="B226">Yamanaka et al., 2008</xref>; <xref ref-type="bibr" rid="B43">de Boer et al., 2014</xref>) has also been examined in mutant <italic>SOD1</italic>-transgenic mouse and cellular models. Mutations in the RNA-binding protein (RBP) <italic>TAR DNA-binding protein</italic> (<italic>TARDBP</italic> encoding TDP-43) can result in ALS (<xref ref-type="bibr" rid="B91">Kabashi et al., 2008</xref>; <xref ref-type="bibr" rid="B175">Rutherford et al., 2008</xref>), and cytoplasmic TDP-43 inclusions have been reported in over 90% of cases of sporadic ALS (<xref ref-type="bibr" rid="B119">Mackenzie et al., 2010</xref>). In 2009, <italic>fused in sarcoma</italic> (<italic>FUS</italic>) was determined in 2009 to be the causative gene of ALS (<xref ref-type="bibr" rid="B106">Kwiatkowski et al., 2009</xref>; <xref ref-type="bibr" rid="B206">Vance et al., 2009</xref>). FUS and TDP-43 have similar structural characteristics, including an RNA recognition motif (RRM), a nuclear export signal (NES), a nuclear localization signal (NLS), and prion-like domains (PrLDs) (<xref ref-type="bibr" rid="B96">Kapeli et al., 2017</xref>). The C-terminal NLS site regulates the nucleocytoplasmic localization of FUS and is a hotspot for mutations in familial ALS (<xref ref-type="bibr" rid="B106">Kwiatkowski et al., 2009</xref>; <xref ref-type="bibr" rid="B206">Vance et al., 2009</xref>; <xref ref-type="bibr" rid="B195">Suzuki et al., 2010</xref>; <xref ref-type="bibr" rid="B149">Nishiyama et al., 2017</xref>). Abnormal phase separation of FUS is involved in this pathomechanism (<xref ref-type="bibr" rid="B71">Guo et al., 2018</xref>; <xref ref-type="bibr" rid="B79">Hofweber et al., 2018</xref>; <xref ref-type="bibr" rid="B166">Qamar et al., 2018</xref>). NLS mutations impair the nuclear import of FUS, and the level of mislocalized cytoplasmic FUS is correlated to the severity of the clinical ALS phenotypes (<xref ref-type="bibr" rid="B50">Dormann et al., 2010</xref>). In addition, recent reports have demonstrated that the abnormal NLS function results in the aberrant accumulation of mutant FUS in the cytoplasm (<xref ref-type="bibr" rid="B82">Ichiyanagi et al., 2016</xref>; <xref ref-type="bibr" rid="B71">Guo et al., 2018</xref>; <xref ref-type="bibr" rid="B79">Hofweber et al., 2018</xref>; <xref ref-type="bibr" rid="B166">Qamar et al., 2018</xref>; <xref ref-type="bibr" rid="B231">Yoshizawa et al., 2018</xref>). Previous studies have found that the toxic gain of function occurring with mutant <italic>FUS</italic> is crucial for neurodegeneration (<xref ref-type="bibr" rid="B180">Scekic-Zahirovic et al., 2016</xref>; <xref ref-type="bibr" rid="B184">Sharma et al., 2016</xref>; <xref ref-type="bibr" rid="B186">Shiihashi et al., 2016</xref>).</p>
<p>A hexanucleotide repeat expansion in <italic>chromosome 9 open reading frame 72</italic> (<italic>C9orf72</italic>) (<xref ref-type="bibr" rid="B47">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="B169">Renton et al., 2011</xref>) is the most common cause of ALS when examined in Western countries (<xref ref-type="bibr" rid="B11">Balendra and Isaacs, 2018</xref>). Loss of function of C9ORF72 (<xref ref-type="bibr" rid="B30">Burberry et al., 2016</xref>; <xref ref-type="bibr" rid="B153">O’Rourke et al., 2016</xref>), toxic gain of function of C9ORF72 due to repeat RNA (<xref ref-type="bibr" rid="B158">Peters et al., 2015</xref>; <xref ref-type="bibr" rid="B85">Jiang et al., 2016</xref>), and toxic gain of function due to proteins with dipeptide repeats resulting from repeat-associated non-ATG translation (<xref ref-type="bibr" rid="B136">Mori et al., 2013</xref>; <xref ref-type="bibr" rid="B107">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="B132">Mizielinska et al., 2014</xref>; <xref ref-type="bibr" rid="B214">Wen et al., 2014</xref>; <xref ref-type="bibr" rid="B34">Chew et al., 2015</xref>) have been suggested as disease mechanisms.</p>
<p>These findings are mainly focused on the event in the cytoplasm of MNs. Actually, long axons, which have lengths of up to 100 cm in humans, are characteristic of MN morphology, and connect the soma of MNs to the skeletal muscles. In ALS, MNs are dysfunctional due to axonal degeneration (<xref ref-type="bibr" rid="B56">Ferraiuolo et al., 2011</xref>), that occurs prior to the motor phenotype in ALS (<xref ref-type="bibr" rid="B59">Fischer et al., 2004</xref>; <xref ref-type="bibr" rid="B174">Roy et al., 2005</xref>). Consistent with this observation, transgenic models of ALS also demonstrate abnormal axons and other degenerative processes, followed by the death of MNs (<xref ref-type="bibr" rid="B9">Armstrong and Drapeau, 2013</xref>; <xref ref-type="bibr" rid="B204">Tian et al., 2016</xref>; <xref ref-type="bibr" rid="B62">Fujimori, 2018</xref>). Other studies have revealed that axonal damage occurs earlier than the death of cell bodies and subsequent symptoms in patients; such symptoms become apparent only after the loss of many MNs (<xref ref-type="bibr" rid="B42">Dadon-Nachum et al., 2011</xref>).</p>
<p>Various reviews have described the physiological and pathological features of neuronal axons, including cargo transport within axons, local translation, and the axonal transcriptome (<xref ref-type="bibr" rid="B89">Jung et al., 2012</xref>; <xref ref-type="bibr" rid="B121">Maday et al., 2014</xref>; <xref ref-type="bibr" rid="B14">Batista and Hengst, 2016</xref>; <xref ref-type="bibr" rid="B145">Neto et al., 2016</xref>; <xref ref-type="bibr" rid="B23">Brady and Morfini, 2017</xref>; <xref ref-type="bibr" rid="B45">De Vos and Hafezparast, 2017</xref>). However, because primary neurons from patients cannot be easily obtained and because axons produce low sample yields and are difficult to culture, the details of the pathological mechanisms of ALS remain unclear. To further elucidate the resilience and pathomechanisms in MN axons, this review summarizes omics analyses of the axon compartment using microfluidic devices and <italic>ex vivo</italic> samples. Intra-axonal transcription and local axonal translation are the mechanisms of ALS emerging in the field, as discussed in the following.</p>
</sec>
<sec id="S2">
<title>Accumulating Evidence of Axonal Dysfunction in ALS</title>
<p>The global pathomechanisms of axons in ALS are considered next, in an overview of the current knowledge of axonal events in MNs. This section classifies the pathomechanisms of axonal dysfunction into six subsections, including neuronal cytoskeleton, cargo transport within axons, axonal energy supply, clearance of junk protein, neuromuscular junctions (NMJs), and aberrant axonal branching (<xref ref-type="fig" rid="F1">Figure 1</xref>). As mentioned in the introduction, an increasing number of genes have been found as causative or associated genes for ALS. Evidence of axon pathomechanisms from the genetics of ALS is also accumulating (<xref ref-type="table" rid="T1">Table 1</xref>). These mechanisms are explained in each subsection.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Proposed pathomechanism of ALS in axon compartments. (1) Neuronal cytoskeleton; (2) cargo transport within axons; (3) axonal energy supply; (4) clearance of junk protein; (5) Neuromuscular junction (NMJs); (6) aberrant axonal branching; (7) Axonal translation; (8) Intra-axonal transcription factors are prominent features of the proposed pathomechanism.</p>
</caption>
<graphic xlink:href="fnins-14-00194-g001"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Motor neuron disease-associated mutations and axonal pathology.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Disease</td>
<td align="center" colspan="1" rowspan="1" valign="top">Gene</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Axonal pathology</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS1</td>
<td align="center" colspan="1" rowspan="1" valign="top">SOD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Superoxide dismutase 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired transport of mitochondria, microtubule stability, modulation of motor proteins via p38 MAP kinase etc.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS2</td>
<td align="center" colspan="1" rowspan="1" valign="top">ALS2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Alsin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired endocytic trafficking, signaling endosomes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS5/SPG11</td>
<td align="center" colspan="1" rowspan="1" valign="top">SPG11</td>
<td align="left" colspan="1" rowspan="1" valign="top">Spatacsin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Axonal destabilization, reduced tubulin acetylation, reduced anterograde vesicle transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS6</td>
<td align="center" colspan="1" rowspan="1" valign="top">FUS</td>
<td align="left" colspan="1" rowspan="1" valign="top">FUS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective transport of mitochondria, aberrant microtubule acetylation, NMJ deformity, aberrant axon branching, Fos-B overexpression</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS8</td>
<td align="center" colspan="1" rowspan="1" valign="top">VAPB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vesicle-associated membrane protein-associated protein B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired transport of mitochondria and vesicles</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS10</td>
<td align="center" colspan="1" rowspan="1" valign="top">TARDBP</td>
<td align="left" colspan="1" rowspan="1" valign="top">TAR DNA-binding protein 43</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective transport of mitochondria and mRNP granules; reduced expression of dynactin 1; aberrant microtubule stability/acetylation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS17</td>
<td align="center" colspan="1" rowspan="1" valign="top">CHMP2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Charged multivesicular body protein 2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired endocytic trafficking, signaling endosomes</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS12</td>
<td align="center" colspan="1" rowspan="1" valign="top">OPTN</td>
<td align="left" colspan="1" rowspan="1" valign="top">optineurin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Progressive dysmyelination and axonal degeneration through engagement of necroptotic machinery in the CNS, including RIPK1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS18</td>
<td align="center" colspan="1" rowspan="1" valign="top">PFN1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Profilin l</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased bound actin levels and can inhibit axon outgrowth. Primary motor neurons expressing mutant PFN1 display smaller</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS22</td>
<td align="center" colspan="1" rowspan="1" valign="top">TUBA4A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tubulin, alpha 4a</td>
<td align="left" colspan="1" rowspan="1" valign="top">Destabilization of microtubules, general transport defect</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS23</td>
<td align="center" colspan="1" rowspan="1" valign="top">ANXA11</td>
<td align="left" colspan="1" rowspan="1" valign="top">annexin All</td>
<td align="left" colspan="1" rowspan="1" valign="top">Molecular tether between lysosomes and RNA granules in axon</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS25/SPGIO</td>
<td align="center" colspan="1" rowspan="1" valign="top">KIF5A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kinesin heavy chain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced kinesin-1 mediated transport, impaired neurofilament transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FALS/HMN7B/Perry syndrome</td>
<td align="center" colspan="1" rowspan="1" valign="top">DCTN1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dynactin 1 (p150, glued homolog, Drosophila)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered axonal transport and vesicle trafficking, impaired signaling endosome trafficking</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FTDALS1</td>
<td align="center" colspan="1" rowspan="1" valign="top">C9orf72</td>
<td align="left" colspan="1" rowspan="1" valign="top">C90RF72</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective transport of mitochondria</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SPG4</td>
<td align="center" colspan="1" rowspan="1" valign="top">SPAST</td>
<td align="left" colspan="1" rowspan="1" valign="top">Spastin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Destabilization of microtubules, impaired transport of mitochondria and vesicles</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SPG30</td>
<td align="center" colspan="1" rowspan="1" valign="top">KIF1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kinesin Family Member 1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced kinesin-3 mediated transport</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SBMA</td>
<td align="center" colspan="1" rowspan="1" valign="top">AR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Androgen receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Defective retrograde and anterograde transport, modulation of motor proteins via JNK</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Modified from <xref ref-type="bibr" rid="B121">Maday et al. (2014)</xref>; <xref ref-type="bibr" rid="B45">De Vos and Hafezparast (2017)</xref>, and <xref ref-type="bibr" rid="B66">Ghasemi and Brown (2018)</xref>. Also refer to OMIM (<ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link>) as of June 2019.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<sec id="S2.SS1">
<title>Neuronal Cytoskeleton</title>
<p>The axon can be visualized as a railway, and the electric signal should be transferred from one train terminal station (the cell body) to another terminal station (the skeletal muscle). Mutations in genes associated with microtubules have been identified as the causative events in ALS.</p>
<p>Several variants of the gene encoding α-tubulin, <italic>TUBA4A</italic>, destabilize the microtubule network and reduce the repolymerization capability of this network (<xref ref-type="bibr" rid="B188">Smith et al., 2014</xref>). A missense mutation in the <italic>tubulin-specific chaperone E</italic> gene, causing MN degeneration in the progressive motor neuronopathy model mouse, ends in microtubule and axonal defects similar to those induced by the ALS-linked <italic>TUBA4A</italic> variation in patients (<xref ref-type="bibr" rid="B21">Bommel et al., 2002</xref>; <xref ref-type="bibr" rid="B124">Martin et al., 2002</xref>).</p>
<p>Mutations in <italic>profilin 1</italic> (<italic>PFN1</italic>) can also lead to familial ALS. PFN1 converts monomeric actin to filamentous actin. Ubiquitinated aggregates are present in cells that express mutant <italic>PFN1</italic>, and many of these aggregates include TDP-43, which is associated with ALS (<xref ref-type="bibr" rid="B221">Wu et al., 2012</xref>). Such cells also have lower levels of bound actin and block axon growth. Primary MNs that harbor mutant <italic>PFN1</italic> have a lower ratio of monomeric to filamentous actin and smaller growth cones. The PFN1 transgenic mouse has also been observed to recapitulate the phenotype of MN disease (<xref ref-type="bibr" rid="B58">Fil et al., 2017</xref>).</p>
<p>NIMA (never in mitosis gene A)-related kinase 1 (NEK1) has been linked to cilia formation, microtubule stability, and neuronal morphology (<xref ref-type="bibr" rid="B202">Thiel et al., 2011</xref>). The <italic>NEK1</italic> gene was identified as a susceptibility factor for ALS (<xref ref-type="bibr" rid="B24">Brenner et al., 2016</xref>; <xref ref-type="bibr" rid="B99">Kenna et al., 2016</xref>). Using <italic>in vivo</italic> imaging, axonal degeneration was identified as an early event in the <italic>SOD1</italic> and <italic>C9ORF72</italic> repeat expansion mouse models of ALS (<xref ref-type="bibr" rid="B204">Tian et al., 2016</xref>). Neurofilament L transcripts are reduced in ALS (<xref ref-type="bibr" rid="B16">Bergeron et al., 1994</xref>). Neurofilaments are also found in a spheroid structure (large axonal swelling) (<xref ref-type="bibr" rid="B39">Corbo and Hays, 1992</xref>). Neurofilament light (NFL) and phosphorylated neurofilament heavy (pNFH) are also known as biomarkers for ALS (<xref ref-type="bibr" rid="B26">Brettschneider et al., 2006</xref>; <xref ref-type="bibr" rid="B193">Steinacker et al., 2016</xref>).</p>
<p>Thus, a dysfunctional cytoskeleton plays a role in ALS pathogenesis.</p>
</sec>
<sec id="S2.SS2">
<title>Cargo Transport Within Axons</title>
<p>Maintenance of the function and structure of all types of cells in mammals requires the intracellular transport of cargo. This transport is especially important in neurons because of their axonal and cell body polarization (<xref ref-type="bibr" rid="B45">De Vos and Hafezparast, 2017</xref>). Proteins and mRNA, as well as organelles, are generally synthesized in the soma and transported along the axon. Proper transport is required for the distribution of this cargo at the right time and place in the axon. Using electron microscopy of autopsy samples from ALS cases, defects in the cargo transport within axon transport in ALS have been observed. The studies of this transport defect revealed that the proximal axons of large MNs harbor abnormal accumulation of mitochondria, phosphorylated neurofilaments, and lysosomes (<xref ref-type="bibr" rid="B77">Hirano et al., 1984a</xref>, <xref ref-type="bibr" rid="B78">b</xref>; <xref ref-type="bibr" rid="B151">Okada et al., 1995</xref>; <xref ref-type="bibr" rid="B173">Rouleau et al., 1996</xref>). In addition, spheroids present in the axons contain different types of vesicles, lysosomes, mitochondria, neurofilaments, and microtubules (<xref ref-type="bibr" rid="B45">De Vos and Hafezparast, 2017</xref>). The accumulation of phosphorylated neurofilaments at the initial segment of MN axons is a major pathological characteristic of ALS (<xref ref-type="bibr" rid="B1">Ackerley et al., 2004</xref>; <xref ref-type="bibr" rid="B23">Brady and Morfini, 2017</xref>).</p>
<p>Aberrant cargo transport within axons occurs early in ALS disease progression (<xref ref-type="bibr" rid="B218">Williamson and Cleveland, 1999</xref>; <xref ref-type="bibr" rid="B44">De Vos et al., 2007</xref>). For example, an altered transport of mitochondria in axons has been demonstrated in two different mutant <italic>SOD1</italic>-G93A transgenic mouse models of ALS (<xref ref-type="bibr" rid="B122">Magrane et al., 2014</xref>). The slow anterograde transport of cytoskeletal components is decreased during the months prior to the initial neurodegeneration in mutant <italic>SOD1</italic>-G37R transgenic mice, a change that has been exhibited using metabolic labeling studies (<xref ref-type="bibr" rid="B218">Williamson and Cleveland, 1999</xref>). In mutant <italic>SOD1</italic>-G93A transgenic mouse models, inhibiting p38 MAPK α rescues retrograde cargo transport defects within axons (<xref ref-type="bibr" rid="B67">Gibbs et al., 2018</xref>).</p>
<p>TDP-43 functions as an mRNA transporter across the axonal cytoskeleton, and ALS-related mutations in TDP-43 alter this transport function (<xref ref-type="bibr" rid="B4">Alami et al., 2014</xref>). Mitotracker and Lysotracker experiments in <italic>FUS</italic>-mutant iPSC-derived MNs have demonstrated that defects in the cargo transport within axons can be rescued by histone deacetylase 6 inhibition (<xref ref-type="bibr" rid="B72">Guo et al., 2017</xref>).</p>
<p>Mutations in the genes that code for the motor protein dynactin (<italic>DCTN1</italic>) (<xref ref-type="bibr" rid="B165">Puls et al., 2003</xref>) have been identified in the genetic analyses of familial ALS. Mutant dynactin binds weakly to microtubules, compared with the binding of wild-type proteins. ALS and slowly progressing, autosomal dominant, distal hereditary motor neuropathy in vocal paresis (HMN7B) are due to loss-of-function mutations in <italic>DCTN1</italic> (<xref ref-type="bibr" rid="B165">Puls et al., 2003</xref>; <xref ref-type="bibr" rid="B140">Munch et al., 2004</xref>; <xref ref-type="bibr" rid="B228">Yan et al., 2015</xref>). DCTN1 expression is also found to be downregulated in ALS-derived autopsy samples (<xref ref-type="bibr" rid="B86">Jiang et al., 2005</xref>).</p>
<p><italic>Kinesin family member 5A</italic> (<italic>KIF5A</italic>) is a newly identified gene that plays a role in ALS (<xref ref-type="bibr" rid="B25">Brenner et al., 2018</xref>; <xref ref-type="bibr" rid="B146">Nicolas et al., 2018</xref>). Mutations that occur in the N-terminal motor domain of KIF5A cause an autosomal dominant type of hereditary spastic paraplegia known as spastic paraplegia (SPG)10, as well as Charcot–Marie–Tooth disease type 2 (<xref ref-type="bibr" rid="B57">Fichera et al., 2004</xref>). In contrast, mutations associated with ALS are mainly found in the C-terminal domain, which is important for binding cargo. Patients with loss-of-function <italic>KIF5A</italic> mutations have longer survival times than those with typical ALS (<xref ref-type="bibr" rid="B25">Brenner et al., 2018</xref>; <xref ref-type="bibr" rid="B146">Nicolas et al., 2018</xref>). Mutations in <italic>KIF5A</italic>, as well as <italic>KIF1A</italic>, which are loss-of-function mutations, are present in the motor or neck domains (<xref ref-type="bibr" rid="B51">Ebbing et al., 2008</xref>; <xref ref-type="bibr" rid="B37">Citterio et al., 2015</xref>).</p>
<p>In addition to MNs, mature sensory axons also possess a complex series of mRNA. A microtubule-stabilizing agent, paclitaxel, which impairs cargo transport within axons, results in sensory neuropathy (<xref ref-type="bibr" rid="B70">Gumy et al., 2011</xref>). Defects in the cargo transport within axons are common to various neurodegenerative diseases. Impaired cargo transport in axons can cause neurodegeneration (<xref ref-type="bibr" rid="B131">Millecamps and Julien, 2013</xref>).</p>
</sec>
<sec id="S2.SS3">
<title>Axonal Energy Supply</title>
<p>The mitochondria play an important role in meeting the axonal energy demand as they generate ATP through oxidative phosphorylation (<xref ref-type="bibr" rid="B33">Chamberlain and Sheng, 2019</xref>). Following their synthesis in the cell body, the mitochondria enter the axon where they undergo robust trafficking and accumulate at the nodes of Ranvier to meet metabolic needs (<xref ref-type="bibr" rid="B232">Zhang et al., 2012</xref>). Disruption of the mitochondrial activity, transport proteins, and microtubule association likely leads to dysfunctional mitochondrial transport in neurodegenerative diseases. Energy deficits in injured axons are caused by damage to the mitochondria following damage to axons, a decrease in mitochondrial transport in axons of mature neurons, and an increased energy consumption (<xref ref-type="bibr" rid="B234">Zhou et al., 2016</xref>). During regeneration, the axons adapt to this increased energy demand by changing the dynamics of the mitochondria (<xref ref-type="bibr" rid="B103">Kiryu-Seo and Kiyama, 2019</xref>). Mutations in <italic>RAPGEF2</italic> mutations impair microtubule stability and the mitochondria distribution in axons (<xref ref-type="bibr" rid="B76">Heo et al., 2018</xref>). Reduction in mitochondrial Rho GTPase 1 (Miro 1), the outer mitochondrial membrane protein, leads to anterograde axonal transport defects (<xref ref-type="bibr" rid="B133">Moller et al., 2017</xref>). The imbalance between mitochondrial fission and fusion leads to abnormal mitochondrial morphology, underlies axonal damage, and is a potential therapeutic target for treating SPG15 and SPG48 (<xref ref-type="bibr" rid="B48">Denton et al., 2018</xref>). The ER and mitochondria form complex sites of interactions known as mitochondria-associated membranes (<xref ref-type="bibr" rid="B65">Gentile et al., 2019</xref>). Decreased ER-mitochondria association can occur as a result of loss-of-function mutations in <italic>SIGMAR1</italic>, leading to impaired retrograde transport and, ultimately, to axonal degeneration and MN death (<xref ref-type="bibr" rid="B17">Bernard-Marissal et al., 2015</xref>; <xref ref-type="bibr" rid="B213">Watanabe et al., 2016</xref>).</p>
<p>Astrocytes and oligodendrocytes may meet the axonal energy demand (<xref ref-type="bibr" rid="B94">Kang et al., 2010</xref>; <xref ref-type="bibr" rid="B111">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="B139">Morrison et al., 2013</xref>). A deficiency in monocarboxylate transporter 1 (MCT1) was observed in oligodendroglia in the ventral cord of <italic>SOD1</italic> transgenic mice and in the motor cortex of ALS patients (<xref ref-type="bibr" rid="B95">Kang et al., 2013</xref>; <xref ref-type="bibr" rid="B159">Philips et al., 2013</xref>). The removal of the <italic>SOD1</italic> mutation from oligodendroglial precursor cells was observed to result in marked attenuation of the progression of the disease (<xref ref-type="bibr" rid="B95">Kang et al., 2013</xref>). Reducing the expression of <italic>MCT1</italic> in oligodendroglia is the pathomechanism involving the energy supply that contributes to MN degeneration in ALS.</p>
</sec>
<sec id="S2.SS4">
<title>Clearance of Junk Protein</title>
<p>The ubiquitin proteasome and autophagy clearance systems are significant homeostatic processes engaged in eliminating defective organelles and aggregated proteins throughout the life span of the neuron. Impairment of the ubiquitin proteasome degradation system in MNs has been reported to replicate the ALS phenotype in mice (<xref ref-type="bibr" rid="B199">Tashiro et al., 2012</xref>). Mice with MN-specific, conditional knockout of the proteasome subunit <italic>Rpt3</italic> exhibit locomotor dysfunction, progressive MN loss, and gliosis (<xref ref-type="bibr" rid="B199">Tashiro et al., 2012</xref>). Constitutive autophagy in neurons also maintains cellular homeostasis by balancing the synthesis and degradation of proteins, particularly within the distal axonal processes (<xref ref-type="bibr" rid="B120">Maday and Holzbaur, 2016</xref>). Several genes, such as <italic>valosin-containing protein</italic>, are involved in the protein degradation process (<xref ref-type="bibr" rid="B87">Johnson et al., 2010</xref>).</p>
<p>What about in the axon fraction? Disruption of the endosomal-lysosomal system due to ALS2/Alsin loss exacerbates the phenotype of <italic>SOD1</italic>-H46R transgenic mice by accelerating the accumulation of misfolded proteins and immature vesicles in the spinal cord (<xref ref-type="bibr" rid="B73">Hadano et al., 2010</xref>). In the early symptomatic and even presymptomatic <italic>SOD1</italic>-H46R transgenic mice, degenerating and swollen spinal axons with the accumulation of autophagosome-like vesicles have been observed (<xref ref-type="bibr" rid="B73">Hadano et al., 2010</xref>). A recent study also reported impairment of the degradation of autophagic vacuoles that engulf damaged mitochondria from distal axons in the <italic>SOD1</italic>-G93A transgenic mouse model (<xref ref-type="bibr" rid="B224">Xie et al., 2015</xref>). The clearance of dysfunctional mitochondria from axons may be mediated by syntaphilin, a mitochondria-anchoring protein, which is expressed at high levels in the early disease stages of ALS in MNs (<xref ref-type="bibr" rid="B114">Lin et al., 2017</xref>). <italic>FUS</italic> mutation causes axonal retention of the FUS protein prior to its aggregation, which is caused by poly(ADP-ribose) polymerase-dependent DNA response signaling (<xref ref-type="bibr" rid="B143">Naumann et al., 2018</xref>). The authors of this review also observed the accumulation of mutant FUS protein in the neurites of <italic>FUS</italic>-mutant induced pluripotent stem cell (iPSC)-derived MNs (<xref ref-type="bibr" rid="B3">Akiyama et al., 2019</xref>).</p>
<p><italic>Optineurin</italic> (<italic>OPTN</italic>) mutations are implicated in both familial and sporadic ALS (<xref ref-type="bibr" rid="B126">Maruyama et al., 2010</xref>). OPTN binds to ubiquitin and regulates NFκB activation and apoptosis (<xref ref-type="bibr" rid="B142">Nakazawa et al., 2016</xref>). OPTN is also involved in several selective autophagy processes regulated by TBK1 (<xref ref-type="bibr" rid="B112">Li et al., 2016</xref>). Receptor-interacting kinase (RIPK) 1-dependent signaling is suppressed by OPTN through the regulation of its turnover (<xref ref-type="bibr" rid="B83">Ito et al., 2016</xref>). OPTN loss leads to progressive demyelination and axonal degeneration through the activation of necroptotic machinery in the central nervous system (CNS) (<xref ref-type="bibr" rid="B83">Ito et al., 2016</xref>). These observations suggest that RIPK1 and RIPK3 are significant in the process of progressive axonal degeneration.</p>
<p>A novel variant in <italic>UBQLN4</italic> compromises motor axon morphogenesis in zebrafish, impairing the proteasomal function (<xref ref-type="bibr" rid="B52">Edens et al., 2017</xref>; <xref ref-type="bibr" rid="B138">Morrice et al., 2018</xref>). Based on these reports, the clearance of junk protein is important in the compartment of the MN axon.</p>
</sec>
<sec id="S2.SS5">
<title>NMJs</title>
<p>Amyotrophic lateral sclerosis can be redefined as a distal axonopathy disease, because many molecular changes influencing MN degeneration occur at the NMJ (<xref ref-type="bibr" rid="B134">Moloney et al., 2014</xref>). The NMJ is a highly specialized synapse, that controls signals between muscles and nerves for skeletal muscle function. Neuromuscular remodeling precedes loss of the motor unit in the mutant <italic>SOD1</italic>-G37R transgenic mouse model (<xref ref-type="bibr" rid="B125">Martineau et al., 2018</xref>).</p>
<p>Certain molecules, including galectin-1 (<xref ref-type="bibr" rid="B55">Ferraiuolo et al., 2007</xref>; <xref ref-type="bibr" rid="B161">Plachta et al., 2007</xref>), CD44 (<xref ref-type="bibr" rid="B181">Schmidt et al., 2011</xref>), and amyloid precursor protein (<xref ref-type="bibr" rid="B29">Bryson et al., 2012</xref>), affect the function of NMJ. Axon guidance molecules affecting the stability of the cytoskeleton, such as Semaphorin 3A (<xref ref-type="bibr" rid="B207">Venkova et al., 2014</xref>), Ephrin A4 (<xref ref-type="bibr" rid="B197">Takata et al., 2013</xref>), and Nogo-A (<xref ref-type="bibr" rid="B164">Pradat et al., 2007</xref>), have been reported to alter the function of the NMJ in the early stage of ALS. The loss of mitofusin 2 in neurons causes NMJ dysfunction, whereas the upregulation of mitofusin 2 ameliorates the phenotype of mutant <italic>SOD1</italic>-G93A transgenic mice (<xref ref-type="bibr" rid="B212">Wang et al., 2018</xref>).</p>
<p>The expression of mutant <italic>FUS</italic> or <italic>FUS</italic> knockdown in zebrafish results in the impairment of motor activity and reduces quantal transmission at NMJs, indicating loss and gain of function of FUS (<xref ref-type="bibr" rid="B9">Armstrong and Drapeau, 2013</xref>). These changes in FUS culminate in presynaptic dysfunction at the NMJ (<xref ref-type="bibr" rid="B9">Armstrong and Drapeau, 2013</xref>). There is evidence that FUS plays multiple roles in the nucleus and axonal compartments involved in NMJ maintenance and axonal transport (<xref ref-type="bibr" rid="B182">Schoen et al., 2015</xref>; <xref ref-type="bibr" rid="B190">So et al., 2018</xref>). FUS mediates the regulation of acetylcholine receptor transcription at NMJ and is dysregulated in ALS (<xref ref-type="bibr" rid="B160">Picchiarelli et al., 2019</xref>).</p>
<p>C9ORF72 was identified on the presynaptic side where the protein interacts with Rab3 protein family members, suggesting that it has a role in the regulation of synaptic vesicle functions as a guanine nucleotide exchange factor (<xref ref-type="bibr" rid="B61">Frick et al., 2018</xref>).</p>
<p>In <italic>Drosophila</italic>, the protein Arc1 is a component of the capsid-like structures that bind <italic>DARC1</italic> mRNA in neurons. These capsids are included in the extracellular vesicles that are transferred across the NMJ from MNs to the muscle cells (<xref ref-type="bibr" rid="B10">Ashley et al., 2018</xref>). The transport of mRNA across the NMJ via these retrovirus-like capsids and extracellular vesicles is required for synaptic plasticity (<xref ref-type="bibr" rid="B10">Ashley et al., 2018</xref>). Dipeptide repeat proteins related to C9ORF72 spread between cells <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B216">Westergard et al., 2016</xref>). Tau is another protein that is transported from donor cells to recipient cells through the cell culture medium (<xref ref-type="bibr" rid="B222">Wu et al., 2016b</xref>). Evidence suggests that the mechanism of pathogenic molecular transfer, termed the prion hypothesis, may be activated in the extracellular space and across the NMJ synapses during degeneration of the motor cortex with centrifugal spreading (<xref ref-type="bibr" rid="B63">Furukawa et al., 2011</xref>; <xref ref-type="bibr" rid="B150">Nonaka et al., 2013</xref>; <xref ref-type="bibr" rid="B162">Porta et al., 2018</xref>).</p>
</sec>
<sec id="S2.SS6">
<title>Aberrant Axonal Branching</title>
<p>Axonal branching is a fundamental mechanism of nervous system neuroplasticity (<xref ref-type="bibr" rid="B129">Menon and Gupton, 2018</xref>). Accumulating evidence suggests that aberrant axonal branching is involved in the pathomechanisms of ALS.</p>
<p>Overexpression of mutant human <italic>TARDBP</italic> in zebrafish embryos induces a phenotype that includes shorter MN axons, premature and increased branching, and abnormal swimming (<xref ref-type="bibr" rid="B90">Kabashi et al., 2010</xref>). On the other hand, overexpression of progranulin rescues mutant <italic>TARDBP</italic>-induced aberrant axonal branching and short axonal outgrowth (<xref ref-type="bibr" rid="B110">Laird et al., 2010</xref>).</p>
<p>Injection of morpholino antisense oligonucleotides to inhibit the translation of target mRNA and to knock down <italic>SMN</italic> in zebrafish embryos significantly increases MN branching (<xref ref-type="bibr" rid="B127">McWhorter et al., 2003</xref>). C9ORF72 modulates the activity of the small GTPases, resulting in increased activity of LIM kinases 1 and 2 and regulation of axonal actin dynamics (<xref ref-type="bibr" rid="B187">Sivadasan et al., 2016</xref>). Various actin isoforms are expressed in primary mouse MNs, and their transcripts have been observed to be translocated into axons (<xref ref-type="bibr" rid="B135">Moradi et al., 2017</xref>). It is proposed that short hairpin RNA-mediated depletion of α-<italic>actin</italic> reduces axonal filopodia dynamics and disrupts collateral branch formation in developing MNs (<xref ref-type="bibr" rid="B135">Moradi et al., 2017</xref>).</p>
<p>Temporary overexpression of human cyclin-F (<italic>CCNF)</italic> in zebrafish embryos increases the levels of cleaved caspase-3 and cell death in the spinal cord. The mutant <italic>CCNF</italic> zebrafish also developed an MN axonopathy, which consists of shortened primary MN axons and an increased frequency of aberrant axonal branching (<xref ref-type="bibr" rid="B80">Hogan et al., 2017</xref>).</p>
<p>A recent study reported that MNs cultured from mutant <italic>SOD1</italic>-G93A transgenic mouse models exhibit enhanced axonal outgrowth and dendritic branching (<xref ref-type="bibr" rid="B154">Osking et al., 2019</xref>). As the level of branching does not correlate with the severity of the disease, in this study, the authors concluded that axonal branching does not affect the disease process. Increased synaptic activity or branching is considered desirable in the field of psychiatric disease (<xref ref-type="bibr" rid="B183">Shao et al., 2019</xref>). The authors of the present review identified aberrant axonal branching in <italic>FUS</italic>-mutant iPSC-derived MNs (<xref ref-type="bibr" rid="B3">Akiyama et al., 2019</xref>). The sensory axons branching in the presence of nerve growth factor (NGF) can be observed at sites marked by stalled mitochondria. NGF promotes branching through the generation of ATP and active axonal translation of mRNA (<xref ref-type="bibr" rid="B192">Spillane et al., 2013</xref>). The mechanism underlying mitochondrial stalling and growth factor distribution in MNs requires examination.</p>
<p>The meaning of axonal branching might be different in each stage of the development (<xref ref-type="bibr" rid="B89">Jung et al., 2012</xref>). In the embryonic stage, axon pathfinding and synaptic formation are important. However, in the developed stage, aberrant axon branching might have a disadvantage in terms of normal function of signal transmission. The significance of aberrant axonal branching in the neurodegenerative model <italic>in vivo</italic> has not yet been elucidated.</p>
</sec>
</sec>
<sec id="S3">
<title>Omics Profiling of the Axonal Compartment</title>
<p>The previous section provided an overview of the important pathomechanisms of MN axons. These pathomechanisms have been found to influence each other and cannot be entirely separated. This section reviews the omics analysis of the axon compartment in order to obtain an overall understanding of this complex process occurring in an important region of the neuron.</p>
<sec id="S3.SS1">
<title>Lessons From Different Nervous Systems</title>
<p>The rationale for conducting omics analysis of the axon compartment is as follows (<xref ref-type="table" rid="T2">Table 2</xref>). Surprisingly complex, constantly changing transcriptomes are present in mature axons. Thus, axonal mRNA localization is likely to be tightly regulated and to play multiple roles. The ribosomal protein S6 has been observed with immunoelectron microscopy in the axons of embryonic sympathetic and hippocampal neurons grown <italic>in vitro</italic> (<xref ref-type="bibr" rid="B201">Tcherkezian et al., 2010</xref>), indicating that local mRNA translation also occurs in growing axons. Further, the local translation of proteins from mRNAs selectively transported from the soma to the synaptic terminal appears to be involved in the regulation of axon outgrowth and regeneration (<xref ref-type="bibr" rid="B233">Zheng et al., 2001</xref>; <xref ref-type="bibr" rid="B200">Taylor et al., 2009</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Omics analyses of the axon compartment in <italic>in vivo</italic>, <italic>ex vivo</italic>, and <italic>in vitro</italic> models of several types of nervous systems.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Disease modeling</td>
<td align="left" colspan="1" rowspan="1" valign="top">System</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell resource</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Vivo/Vitro</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methodology</td>
<td align="left" colspan="1" rowspan="1" valign="top">Analysis</td>
<td align="left" colspan="1" rowspan="1" valign="top">Core result</td>
<td align="left" colspan="1" rowspan="1" valign="top">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Human iPS-derived motor neuron</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>in vitro</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Separating axon using microfluidics (Jiksak Bioengineering)</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA sequencing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased level of Fos-B mRNA, the binding target of FUS, in FUS-mutant MNs. While Fos-B reduction using si-RNA or an inhibitor ameliorated the observed aberrant axon branching, Fos-B overexpression resulted in aberrant axon branching even in zebrafish model.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B3">Akiyama et al., 2019</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mouse and human stem cell-derived spinal motor axons</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>in vitro</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microfluidics</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA sequencing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Identified 3,500–5,000 transcripts in mouse and human stem cell-derived spinal motor axons, most of which are required for oxidative energy production and ribogenesis. Axons contained transcription factor mRNAs, e.g., Ybx1, with implications for local functions. In SOD1G93A mutant, identifying 121 ALS-dysregulated transcript, including Nrp1, Dbn1, and Nek1, a known ALS-causing gene.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B147">Nijssen et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor</td>
<td align="left" colspan="1" rowspan="1" valign="top">hiPSC-derived motor neuron</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>in vitro</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Permeable inserts culture device</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA sequencing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Discriminate axonal and somatodendritic compartments</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B117">Maciel et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinal ganglion cells (RGCs) exit from the eye primordia from Xenopus laevis embryos</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Axon grow through the 1 μm pores of the transfilter on the Boyden chamber</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pulsed stable isotope labeling of amino acids in cell culture (pSILAC) with ultrasensitive sample preparation technology termed single-pot solid-phase-enhanced sample preparation (SP3)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Axons stimulated by different cues (netrin-1, BDNF, Sema3A) showed distinct signatures with over 100 different nascent protein species</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B31">Cagnetta et al., 2018</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Spinal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dissociated spinal cord culture from ICR mice at E12.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Modified boyden chamber membrane culture system</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA sequencing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Elavl2 and miR-146a, miR-126-5p, miR-99a are shared in axons of lentiviral overexpression of both p.A315T TARDBP and p.G93A SOD1 mutants.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B172">Rotem et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron</td>
<td align="left" colspan="1" rowspan="1" valign="top">Differentiated neurons from human ESC</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>in vitro</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microfluidics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microarray</td>
<td align="left" colspan="1" rowspan="1" valign="top">Confirmed the presence of two well characterized axonal mRNAs in model organisms, β-actin and GAP43, within hESC-neuron projections. oxytocin mRNA localized to these human projections and confirmed its localization using RNA-FISH.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B19">Bigler et al., 2017</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Isolated motor neuron from E12.5 CD-1 mouse spinal cord using p75NTR antibody panning</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xona microfluidics, SND 150 chamber</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA sequencing</td>
<td align="left" colspan="1" rowspan="1" valign="top">Double-random priming transcriptome methods enable to serially diluted total RNA down to 10 pg</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B27">Briese et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinal ganglion cells (RGCs) of mouse</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>in vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Axonal translatome using Axon-TRAP-RiboTag mouse and IP of ribosome mRNAs</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>in vivo</italic> axonal translatome</td>
<td align="left" colspan="1" rowspan="1" valign="top">The embryonic to postnatal axonal translatome comprises an evolving subset of enriched genes with axon-specific roles, suggesting distinct steps in axon wiring, such as elongation, pruning, and synaptogenesis. Adult axons have a complex translatome with strong links to axon survival, neurotransmission and neurodegenerative disease.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B185">Shigeoka et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SMA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Isolated motor neuron from E12.5 CD-1 mouse spinal cord using p75NTR antibody panning</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xona microfluidics, SND 150 chamber</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microarray</td>
<td align="left" colspan="1" rowspan="1" valign="top">Knockdown of SMN, the protein deficient in spinal muscular atrophy, produced a large number of transcript alterations in both compartments. Transcripts associated with axon growth and synaptic activity were down-regulated on the axonal side of smn- deficient motor neurons.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B176">Saal et al., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina</td>
<td align="left" colspan="1" rowspan="1" valign="top">DRG explants dissected from embryonic (E16) and adult (3–5 mo old) from Sprague Dawley rats</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Compartmentalized chamber to isolate mRNA from pure embryonic and adult sensory axons devoid of non-neuronal or cell body contamination</td>
<td align="left" colspan="1" rowspan="1" valign="top">Genome-wide microarray</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tubulin-beta3 (Tubb3) mRNA is present only in embryonic axons, with Tubb3 locally synthesized in axons of embryonic, but not adult neurons where it is transported</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B70">Gumy et al., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retina</td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinal ganglion cell (RGC) axons of two vertebrate species, mouse and Xenopus</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Laser capture microdissection (LCM) to isolate the growth cones</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coupled with unbiased genomewide microarray profiling.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Many presynaptic protein mRNAs are present exclusively in old growth cones. ome receptor transcripts (e.g., EphB4), present exclusively in old growth cones, were equally abundant in young and old cell bodies.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B235">Zivraj et al., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortical</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortical and hippocampal dissociated neurons from embryonic Sprague Dawley rats at E18</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microfluidic chamber with microgrooves (7.5 μm wide, 3 μm high)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microarray</td>
<td align="left" colspan="1" rowspan="1" valign="top">Axonal transcripts are enriched for protein translational machinery, transport, cytoskeleton, and mitochondrial maintenance.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B200">Taylor et al., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">No</td>
<td align="left" colspan="1" rowspan="1" valign="top">Motor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Primary DRG cultures from L4-5 were prepared from Sprague Dawley rats that had been injury conditioned 7 days before by sciatic nerve crush at midthigh level</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>Ex vivo</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dissociated DRGs were plated into tissue culture inserts containing porous membranes (8-μm pores). Axons were isolated after 16-20 h in culture by scraping away the cellular content from the upper or lower membrane surfaces</td>
<td align="left" colspan="1" rowspan="1" valign="top">cDNA microarray</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotrophins (nerve growth factor, brainderived neurotrophic factor, and neurotrophin-3) regulate axonal mRNA levels and use distinct downstream signals to localize individual mRNAs.</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B219">Willis et al., 2007</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Elucidation of what features of axonal function require local translation and determination of the mRNAs that mediate these functions have induced intriguing challenges in the field of axonal biology (<xref ref-type="bibr" rid="B46">Deglincerti and Jaffrey, 2012</xref>; <xref ref-type="bibr" rid="B89">Jung et al., 2012</xref>). Assessment of the axonal transcriptome using microarray studies has identified important axonal mRNAs and has demonstrated the complexity and dynamic nature of the axonal transcriptome (<xref ref-type="bibr" rid="B235">Zivraj et al., 2010</xref>; <xref ref-type="bibr" rid="B70">Gumy et al., 2011</xref>).</p>
<p>In a pioneering study involving omics analysis in axons, more than 200 different mRNAs were identified with cDNA microarray analysis in axons derived from rat with injured sensory neurons (<xref ref-type="bibr" rid="B219">Willis et al., 2007</xref>). Proteins involved in the transcription, synthesis of proteins, intracellular transport, calcium metabolism, mitochondrial functions, and cytoskeletal functions were identified in the study (<xref ref-type="bibr" rid="B219">Willis et al., 2007</xref>). The report raised several important questions regarding axonal translation (<xref ref-type="bibr" rid="B46">Deglincerti and Jaffrey, 2012</xref>), including the question of why transcripts for nuclear proteins are localized to distal axons.</p>
<p>Using a microfluidic chamber enabling the isolation of axons without contamination with non-axonal material, mRNA has been purified from mature CNS axons (<xref ref-type="bibr" rid="B200">Taylor et al., 2009</xref>). The same study also described the localization of catenin-β1 and neurexin-3 mRNA with fluorescence <italic>in situ</italic> hybridization in the axonal compartment (<xref ref-type="bibr" rid="B200">Taylor et al., 2009</xref>). The somatodendritic compartments are enriched in transcripts with postsynaptic functions and in nuclear non-coding RNAs such as <italic>7SK</italic>, whereas transcripts related to translation such as<italic>7SL</italic>, the cytoplasmic non-coding RNA, are upregulated in the compartment of the axon fraction (<xref ref-type="bibr" rid="B27">Briese et al., 2016</xref>).</p>
<p>Transcriptome-wide analyses have revealed numerous transcripts encoding transmembrane or secreted proteins, which comprise about 13% of the total mRNAs found in growth cones (<xref ref-type="bibr" rid="B235">Zivraj et al., 2010</xref>). Transcripts present in axons encode many transmembrane proteins, such as integrins and protocadherins, which are cell adhesion molecules, and EphB4 and Nrp2, which are guidance receptors (<xref ref-type="bibr" rid="B235">Zivraj et al., 2010</xref>). Thus, local translation may change the cell adhesion capacity of axons and allow axons to respond to extracellular signaling molecules (<xref ref-type="bibr" rid="B70">Gumy et al., 2011</xref>). Axons also contain transcripts that code for secreted proteins, including semaphorin and ephrin, which are guidance molecules; BMP1, CTGF, and FGF, which are growth factors; and collagen and TIMP3, which compose and regulate the extracellular matrix. Thus, it is expected that local translation probably plays a role in the regulation of extracellular components by affecting proteins that are secreted from growth cones (<xref ref-type="bibr" rid="B46">Deglincerti and Jaffrey, 2012</xref>). Axons also contain structures that resemble the ER and Golgi. Specific labeling of the ER and Golgi exhibits irregular, punctate staining along the axon, suggesting that axon-specific versions of these organelles may be present in nerve terminals (<xref ref-type="bibr" rid="B130">Merianda et al., 2009</xref>).</p>
<p>The development of compartmentalization has enabled the examination of axon pathology in MN diseases. The knockdown of <italic>SMN</italic>, which encodes the protein that is deficient in spinal muscular atrophy (SMA), was shown to produce numerous transcript alterations in both axon and somatic compartments of the microarray (<xref ref-type="bibr" rid="B176">Saal et al., 2014</xref>). Transcripts associated with axon growth and synaptic activity are downregulated on the axonal side of <italic>SMN</italic>-deficient MNs. Improvements in the handling of small quantities of RNA have led to further progress in this field (<xref ref-type="bibr" rid="B27">Briese et al., 2016</xref>).</p>
<p>Evaluation of cultured spinal cord neurons grown with a compartmented platform and subjected to next-generation sequencing technology revealed that mRNAs and miRNAs are differentially expressed in the somatic compared with the axonal neuronal compartments (<xref ref-type="bibr" rid="B172">Rotem et al., 2017</xref>). In axons with lentiviral overexpression of p.A315T <italic>TARDBP</italic> or p.G93A <italic>SOD1</italic> mutants, <italic>Elavl2</italic>, <italic>miR-146a</italic>, <italic>miR-126-5p</italic>, and <italic>miR-99a</italic> are commonly expressed. Examination of the local transcriptome revealed that the most abundant mRNAs within human embryonic stem cell-derived neuronal projections are functionally similar to the rat axonal transcriptome of cortical neurons (<xref ref-type="bibr" rid="B19">Bigler et al., 2017</xref>).</p>
<p>The use of microfluidic technology has been particularly useful in neuroscience research. Microfluidic platforms have allowed researchers to address specific questions related to axonal guidance, synapse formation, and cargo transport within axons, and led to the development of three-dimensional (3D) CNS models for pharmacological testing and drug screening (<xref ref-type="bibr" rid="B145">Neto et al., 2016</xref>). Human iPSC-derived MNs grown in a culture device with permeable inserts were observed to produce large amounts of enriched axonal material that can be harvested for RNA isolation and sequencing (<xref ref-type="bibr" rid="B117">Maciel et al., 2018</xref>). Transcriptome profiling has revealed axonal and somatodendritic compartment-specific expression.</p>
<p>Recently, Nijissen and colleagues developed a refined method named Axon-seq, combining microfluidics, RNA sequencing, and bioinformatics analysis (<xref ref-type="bibr" rid="B147">Nijssen et al., 2018</xref>). These results demonstrated that the transcriptome of the axon compartment is quite different from that of the soma and includes a smaller number of mRNAs. They identified up to 5,000 mRNAs in mouse and human stem cell-derived MN axons; the functions of the majority of these are oxidative energy and ribosome production. Axons contain transcription factor mRNAs, implicating local functions. Investigation into the response of degenerated ALS motor axons to the <italic>SOD1</italic>-G93A mutation identified 121 ALS-dysregulated transcripts. Among these, <italic>Nrp1</italic> and <italic>Dbn1</italic> are involved in axonal function, and <italic>Nek1</italic> is a known ALS-causative gene (<xref ref-type="bibr" rid="B24">Brenner et al., 2016</xref>; <xref ref-type="bibr" rid="B99">Kenna et al., 2016</xref>; <xref ref-type="bibr" rid="B147">Nijssen et al., 2018</xref>). Axon-seq is an advanced technique for sequencing the RNA in axons, and thus can provide enhanced knowledge about peripheral nerve biology to explain the vulnerability/resilience of MN (<xref ref-type="bibr" rid="B148">Nijssen et al., 2017</xref>; <xref ref-type="bibr" rid="B5">Allodi et al., 2019</xref>) and to identify the treatment of MN diseases.</p>
</sec>
<sec id="S3.SS2">
<title>Development of a Microfluidic Device for Larger-Scale Omics Analysis</title>
<p>Despite the improvement offered by the microfluidic device, harvesting a sufficient volume of lysate from the axon compartment remains challenging. In the process of improving the dimensions of the well and materials, a novel microfluidic device was developed by the authors of this study (<xref ref-type="table" rid="T4">Table 3</xref>). The device enabled comparison of two sets of isogenic <italic>FUS</italic>-mutant iPSC-derived MNs generated using genome editing technology (<xref ref-type="bibr" rid="B88">Joung and Sander, 2013</xref>; <xref ref-type="bibr" rid="B152">Okano and Yamanaka, 2014</xref>), and provided observations of increased branching in <italic>FUS</italic>-mutant MN axons compared with those in isogenic controls (<xref ref-type="bibr" rid="B3">Akiyama et al., 2019</xref>). This phenotype was confirmed using other ALS-causative mutations, including <italic>SOD1</italic> and <italic>TARDBP</italic>. Combining this innovative microfluidic device (<xref ref-type="bibr" rid="B97">Kawada et al., 2017</xref>) with hiPSC-derived MN organoids further revealed the entire <italic>in vitro</italic> profile of the human MN axons. This technique identified increased <italic>Fos-B</italic> mRNA as a binding partner of FUS and as a causative event for aberrant axon morphology both <italic>in vitro</italic> and <italic>in vivo</italic>.</p>
<table-wrap id="T4" position="float">
<label>TABLE 3</label>
<caption>
<p>Comparison of our microfluidic devices with those of previous studies.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuron device</td>
<td align="left" colspan="1" rowspan="1" valign="top">Modified boyden</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nerve organoid device</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Company</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xona Microfluidics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Corning</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jiksak Bioengineering</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dimension</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 D</td>
<td align="left" colspan="1" rowspan="1" valign="top">2 D</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 D (axon bundle)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cell type</td>
<td align="left" colspan="1" rowspan="1" valign="top">Primary mouse motor neuron</td>
<td align="left" colspan="1" rowspan="1" valign="top">Primary mouse motor neuron</td>
<td align="left" colspan="1" rowspan="1" valign="top">iPSCs derived motor neuron</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pore size</td>
<td align="left" colspan="1" rowspan="1" valign="top">1∼3 um</td>
<td align="left" colspan="1" rowspan="1" valign="top">3 um</td>
<td align="left" colspan="1" rowspan="1" valign="top">150∼200 um</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Axon length</td>
<td align="left" colspan="1" rowspan="1" valign="top">150 um</td>
<td align="left" colspan="1" rowspan="1" valign="top">NA</td>
<td align="left" colspan="1" rowspan="1" valign="top">10,000 μm (1 cm)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Retrievable neurons</td>
<td align="left" colspan="1" rowspan="1" valign="top">∼10*3</td>
<td align="left" colspan="1" rowspan="1" valign="top">5 × 10*5</td>
<td align="left" colspan="1" rowspan="1" valign="top">10*4-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">20 pg-</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.3 ng/μl</td>
<td align="left" colspan="1" rowspan="1" valign="top">12 ng (l ng/μl) -</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">References</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B27">Briese et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Bigler et al., 2017</xref>; <xref ref-type="bibr" rid="B147">Nijssen et al., 2018</xref>, etc.</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B172">Rotem et al., 2017</xref>; <xref ref-type="bibr" rid="B117">Maciel et al., 2018</xref>, etc.</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B3">Akiyama et al., 2019</xref>; <xref ref-type="bibr" rid="B97">Kawada et al., 2017</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Morphological changes in MN axon branching have been found to precede MN death in the mutant <italic>SOD1</italic>-G93A transgenic mouse model (<xref ref-type="bibr" rid="B204">Tian et al., 2016</xref>), and abnormal neural branching has been detected in zebrafish that overexpress mutant <italic>FUS</italic> (<xref ref-type="bibr" rid="B9">Armstrong and Drapeau, 2013</xref>). Improvements in axon morphology following suppression of abnormally upregulated <italic>Fos-B</italic> in <italic>FUS</italic> mutants suggested a novel therapeutic candidate for <italic>FUS</italic>-mutant ALS.</p>
<p>Previous studies have also reported that upregulation of <italic>Fos-B</italic> mRNA is associated with increases in spines (<xref ref-type="bibr" rid="B109">Lafragette et al., 2017</xref>; <xref ref-type="bibr" rid="B32">Cahill et al., 2018</xref>) and growth cones (<xref ref-type="bibr" rid="B6">Anastasiadou and Knoll, 2016</xref>). δ<italic>Fos-B</italic> modulates immature spines of the nucleus accumbens in a model of drug addiction (<xref ref-type="bibr" rid="B69">Grueter et al., 2013</xref>). Certain chemical stimulators such as kainic acid lead to neurodegeneration via upregulated expression of immediate early genes, including that of <italic>Fos-B</italic> (<xref ref-type="bibr" rid="B157">Pereno et al., 2011</xref>). The hyperexcitability hypothesis is a major theme in proposing the pathomechanism of ALS (<xref ref-type="bibr" rid="B209">Wainger et al., 2014</xref>). A recent report of activator protein-1 (AP-1) and MN degeneration in the mutant <italic>SOD1</italic>-G93A transgenic mouse model has attracted attention (<xref ref-type="bibr" rid="B18">Bhinge et al., 2017</xref>). Additionally, the suppression of dual leucine zipper kinase, the upstream signal protein for c-Jun (AP-1 family member), may become a therapeutic target for ALS (<xref ref-type="bibr" rid="B18">Bhinge et al., 2017</xref>). Although substantial differences have been reported in <italic>SOD1</italic>-ALS compared with <italic>FUS</italic>-ALS and <italic>TARDBP</italic>-ALS (<xref ref-type="bibr" rid="B62">Fujimori, 2018</xref>), <italic>SOD1</italic>-, <italic>TARDBP</italic>-, and <italic>FUS</italic>-mutant MNs have common features, suggesting a role for AP-1 in the neurodegeneration observed in ALS. The Fos-B protein accumulates abnormally in the MNs of ALS patients, including in sporadic cases. Thus, Fos-B appears to be a potential therapeutic target molecule.</p>
<p>The novel microfluidic device described in the preceding paragraph comprises a large canal that enables the collection of sufficient samples of isolated MN axons for RNA sequencing (<xref ref-type="bibr" rid="B97">Kawada et al., 2017</xref>). This device has proven useful in visualizing the global profile of the axon compartment. Although other types of microfluidic devices, some of which are specific to cell fraction analysis, are available on the market (<xref ref-type="bibr" rid="B27">Briese et al., 2016</xref>; <xref ref-type="bibr" rid="B172">Rotem et al., 2017</xref>), they are typically restricted by the limited amount of specimen obtained (<xref ref-type="table" rid="T4">Table 3</xref>). As only a very small amount of specimen can be analyzed, variation in conditions, such as cell purity and culture procedures, may influence the results. Kawada’s microfluidic device enables analysis with fewer technical biases because it involves the collection of large amounts of macroscopically observable axon bundles. RNA profiles from the axon samples have reproduced the previously reported profiles of the MN axon (<xref ref-type="bibr" rid="B27">Briese et al., 2016</xref>; <xref ref-type="bibr" rid="B172">Rotem et al., 2017</xref>), justifying the methodology of this novel device. Furthermore, the data obtained may provide important resources for the subcellular fractional analysis of stem cell-derived MN axons.</p>
</sec>
<sec id="S3.SS3">
<title>Are These mRNAs Translated in Axons?</title>
<p>An important question is whether these mRNAs are translated in axons or transported to the nucleus/cell body. The importance of axonal translation for CNS maintenance is under debate (<xref ref-type="bibr" rid="B191">Spaulding and Burgess, 2017</xref>). Several types of mature polarized cells utilize asymmetrical mRNA localization as a means of synaptic communication with other types of cells (<xref ref-type="bibr" rid="B225">Xing and Bassell, 2013</xref>). <italic>In vivo</italic>, the longest axons, such as those of mature sensory and motor peripheral neurons, rely most strongly on mRNA transport and local translation to maintain homeostasis.</p>
<p>Upregulation of ribosome synthesis in axons has been found to occur early in the pathogenesis of both mutant <italic>SOD1</italic>-G93A transgenic mouse models and human ALS autopsy samples, which suggests the involvement of Schwann cells in ALS pathology and in aberrant axonal RNA metabolism (<xref ref-type="bibr" rid="B208">Verheijen et al., 2014</xref>). Gene expression analyses of the anterior branch of human obturator MNs biopsied from patients with ALS demonstrated upregulation of a cluster of genes that play important roles in biological processes involving RNA processing and protein metabolism (<xref ref-type="bibr" rid="B170">Riva et al., 2016</xref>).</p>
<p>Direct evidence for neurodegeneration has been obtained from the observation of mRNA transport dysregulation due to mutations in the RBP SMN1, which causes SMA (<xref ref-type="bibr" rid="B211">Wang et al., 2016b</xref>). SMN is present ubiquitously, and its deletion is lethal. However, MNs are more sensitive to SMN reduction than other cell types, possibly because reduced SMN decreases the axonal localization of several mRNAs (<xref ref-type="bibr" rid="B168">Rage et al., 2013</xref>) and inhibits the activity of the mammalian target of rapamycin in axons (<xref ref-type="bibr" rid="B108">Kye et al., 2014</xref>). An additional role for SMN is in the regulation of axonal localization and local translation of <italic>growth-associated protein 43</italic> (<italic>GAP43</italic>) mRNA in growth cones (<xref ref-type="bibr" rid="B54">Fallini et al., 2016</xref>). The overexpression of two mRNA-binding proteins, HuD and IGF2 mRNA-binding protein 1, restores the mRNA and protein levels of GAP43 and has been shown to rescue the axon outgrowth defects in the neurons of an SMA patient (<xref ref-type="bibr" rid="B54">Fallini et al., 2016</xref>).</p>
<p>In previous studies, protein interaction screening intended to elucidate <italic>FUS</italic>-mutant phenotypes also identified several molecules that interact with FUS, including SMN (<xref ref-type="bibr" rid="B227">Yamazaki et al., 2012</xref>; <xref ref-type="bibr" rid="B68">Groen et al., 2013</xref>). Aberrant distribution of SMN in cytosolic FUS accumulations induces SMN reduction in axons. Accumulation of mutant human FUS induces an integrated stress response and reduces protein synthesis in nearby axons (<xref ref-type="bibr" rid="B116">Lopez-Erauskin et al., 2018</xref>).</p>
<p>Non-nuclear pools of splicing factor, proline-glutamine rich (SFPQ) are essential for normal motor development via local mRNA maintenance or processing, and the coiled-coil domain of SFPQ is required for axonal localization (<xref ref-type="bibr" rid="B203">Thomas-Jinu et al., 2017</xref>). The RBPs modulate nuclear processing, intracellular transport, and local translation of target mRNAs for an accurate spatial and temporal gene expression. SFPQ functions as an RBP because it binds to and modulates numerous neuronal mRNAs, including in cells, such as dorsal root ganglion neurons. SFPQ, which has been identified by subcellular compartmentalization analysis (<xref ref-type="bibr" rid="B40">Cosker et al., 2016</xref>; <xref ref-type="bibr" rid="B198">Takeuchi et al., 2018</xref>), has been found to orchestrate spatial gene expression, which is essential for axonal viability.</p>
<p>Local translation is also involved in several neurodevelopmental disorders (<xref ref-type="bibr" rid="B14">Batista and Hengst, 2016</xref>). Local translation defects are associated with fragile X mental retardation and autism spectrum disorders (<xref ref-type="bibr" rid="B98">Kelleher and Bear, 2008</xref>). Fragile X mental retardation protein, which is present in dendritic spines, growth cones, and axons, modulates plasticity (<xref ref-type="bibr" rid="B13">Bassell and Warren, 2008</xref>) and the presynaptic proteome (<xref ref-type="bibr" rid="B35">Christie et al., 2009</xref>; <xref ref-type="bibr" rid="B2">Akins et al., 2012</xref>). In mouse brain slices, loss of the fragile X mental retardation protein was found to perturb the development of presynaptic nerve terminals (<xref ref-type="bibr" rid="B74">Hanson and Madison, 2007</xref>).</p>
<p>Degeneration of motor axons results from mutations in various tRNA synthetases, which is consistent with the notion that local translation of transported mRNA is necessary for axonal homeostasis (<xref ref-type="bibr" rid="B75">He et al., 2015</xref>; <xref ref-type="bibr" rid="B194">Storkebaum, 2016</xref>). Recently, cytoplasmic polyadenylation element-binding protein 4 was found to orchestrate the dysregulation of mRNA expression in autism (<xref ref-type="bibr" rid="B155">Parras et al., 2018</xref>). Identification of a master regulator of RNA metabolism would be beneficial in understanding and treating for both diseases that affect MNs and psychiatric diseases.</p>
<p>Nascent chain tracking is a novel technique for visualizing local translation. This method uses multi-epitope tags and antibody-based fluorescent probes to quantify the dynamics of protein synthesis at the level of individual mRNAs (<xref ref-type="bibr" rid="B137">Morisaki et al., 2016</xref>). Due to its sensitivity and versatility, nascent chain tracking is a useful tool for quantifying mRNA translation kinetics. Synaptic activity can induce mRNA localization and the local translation of β-actin, which stabilizes expanding synapses at dendritic spines (<xref ref-type="bibr" rid="B220">Wu et al., 2016a</xref>; <xref ref-type="bibr" rid="B230">Yoon et al., 2016</xref>). Real-time visualization of mRNA translation in the axonal compartment is an innovative method enabling analysis of axonal pathology <italic>in vivo</italic> (<xref ref-type="bibr" rid="B210">Wang et al., 2016a</xref>; <xref ref-type="bibr" rid="B229">Yan et al., 2016</xref>). The inducible fluorescent probe can be regulated in time and space in neurons and is used to examine the maturation of miRNA. The local maturation of miRNA by synaptic stimulation results in a spatially restricted protein synthesis reduction from the mRNA (<xref ref-type="bibr" rid="B179">Sambandan et al., 2017</xref>). The proteomics approach described in a later section adds to the understanding of the global change of nascent proteins produced in the axon fraction.</p>
</sec>
<sec id="S3.SS4">
<title>Role of Intra-Axonal Transcription Factors</title>
<p>Why transcripts for nuclear proteins are localized to the distal axons is a big question raised by the omics analysis. Fos-B, a mediator of abnormal axonal branching in <italic>FUS</italic>-mutated MNs, is a transcription factor. Another research group also reported dysregulated transcription factors in ALS MNs (<xref ref-type="bibr" rid="B147">Nijssen et al., 2018</xref>). In determining the role of transcription factors in the axon compartment, a comprehensive transcription of the action fraction has identified mRNAs encoding a larger amount of transcription factors and co-factors (<xref ref-type="bibr" rid="B84">Ji and Jaffrey, 2014</xref>). One example is that of axonal STAT3, which is translated locally, activated upon nerve injury, and is transported retrogradely with dynein and importin α5, modulating the survival of peripheral sensory neurons (<xref ref-type="bibr" rid="B15">Ben-Yaakov et al., 2012</xref>). Recently, <italic>Tp53inp2</italic> was reported to be an atypical mRNA regulating axon growth by enhancing the NGF-TrkA pathway independently with translation (<xref ref-type="bibr" rid="B41">Crerar et al., 2019</xref>). Importantly, data have indicated that axonal degeneration shared early molecular change in the neurodegenerative process of neurological disorders in aged populations (<xref ref-type="bibr" rid="B42">Dadon-Nachum et al., 2011</xref>; <xref ref-type="bibr" rid="B196">Tagliaferro and Burke, 2016</xref>; <xref ref-type="bibr" rid="B178">Salvadores et al., 2017</xref>).</p>
<p>In the brain of a person with Alzheimer’s disease, inhibition of local translation of <italic>Atf4</italic> mRNA overproduction eliminates amyloid β-induced cell loss (<xref ref-type="bibr" rid="B12">Baleriola et al., 2014</xref>; <xref ref-type="bibr" rid="B156">Peng et al., 2016</xref>). <italic>Atf4</italic> mRNA translation is controlled by phosphorylation of elongation initiation factor 2a, pivotal for an integrated stress response (<xref ref-type="bibr" rid="B14">Batista and Hengst, 2016</xref>). The role of axonal transcription factors in relation to translated proteins and non-translated RNA requires further elucidation.</p>
</sec>
<sec id="S3.SS5">
<title>Interaction Among the Mechanisms Already Described</title>
<p>The hallmark feature in the majority of autopsy cases of ALS is nuclear depletion and cytoplasmic accumulation of TDP-43 in degenerated neurons (<xref ref-type="bibr" rid="B102">Kim and Taylor, 2017</xref>). Thus, dysfunctional trafficking between the nucleus and cytoplasm likely plays a role in the pathology of ALS (<xref ref-type="bibr" rid="B144">Nedelsky and Taylor, 2019</xref>) and may also be important in normal physiological aging, Huntington’s disease, and Alzheimer’s disease (<xref ref-type="bibr" rid="B144">Nedelsky and Taylor, 2019</xref>). RBPs with prion-like domains (PrLDs) undergo liquid-liquid phase separation to form functional liquids, which can be converted into abnormal hydrogels that contain pathological fibrils that are often seen in neurodegenerative diseases. TDP-43, FUS, heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), and hnRNPA2 are nuclear RBPs with PrLDs that are incorrectly sent to cytoplasmic inclusions in neurodegenerative diseases. Mutations in PrLDs increase the rate of fibril formation and initiate disease (<xref ref-type="bibr" rid="B71">Guo et al., 2018</xref>). Karyopherin-β2, also known as transportin-1, binds the proline-tyrosine NLS and then blocks and reverses FUS, TATA-box-binding protein associated factor (TAF) 15, Ewing sarcoma RBP1 (EWSR1), hnRNPA1, and hnRNPA2 fibril formation. Importin-α and karyopherin-β1 also block and reverse TDP-43 fibril formation. Phase separation, like stress granule formation, is an emerging property of proteins containing PrLD such as FUS (<xref ref-type="bibr" rid="B71">Guo et al., 2018</xref>; <xref ref-type="bibr" rid="B79">Hofweber et al., 2018</xref>; <xref ref-type="bibr" rid="B166">Qamar et al., 2018</xref>; <xref ref-type="bibr" rid="B231">Yoshizawa et al., 2018</xref>). T-cell-restricted intracellular antigen-1 (TIA1) mutations were found to delay stress granule disassembly and to promote the accumulation of granules harboring TDP-43 (<xref ref-type="bibr" rid="B118">Mackenzie et al., 2017</xref>). <italic>C. elegans</italic> TIAR-2/TIA protein functions cell autonomously to inhibit axon regeneration (<xref ref-type="bibr" rid="B7">Andrusiak et al., 2019</xref>). One of the important roles of phase separation is transcription enhancement (<xref ref-type="bibr" rid="B177">Sabari et al., 2018</xref>), which might be related to local translation/transcription. The association between axonal dysfunction and these cytoplasmic events, including phase separation, has not yet been elucidated.</p>
<p>There is emerging evidence of interactions among different processes of axonal pathology in ALS. Annexin A11 (ANXA11), a phosphoinositide-binding protein associated with the RNA granule, has the role of a molecular tether between lysosomes and RNA granules. Such tethering is impaired by the ALS-associated <italic>ANXA11</italic> mutation (<xref ref-type="bibr" rid="B189">Smith et al., 2017</xref>; <xref ref-type="bibr" rid="B113">Liao et al., 2019</xref>). Late endosome bearing mRNA encoding mitochondrial functional molecules stops at mitochondria and these mRNAs are translated on Rab7a endosomes locally in the axon (<xref ref-type="bibr" rid="B36">Cioni et al., 2019</xref>).</p>
<p>In summary, exactly how these complex mechanisms are influenced by each other is still unknown. There is a need for understanding how cytoskeletons are maintained, and how molecules are transported/metabolized/synthesized, or abolished when unnecessary. Elucidating the interaction of these mechanisms might answer the vital question of why MNs are vulnerable in ALS.</p>
</sec>
<sec id="S3.SS6">
<title>Advanced Omics Analysis and Further Consideration</title>
<p>Conducting a comprehensive analysis of the newly produced proteome from limited samples of subcellular compartments that are uncontaminated by the somatodendrite remains a major technical problem (<xref ref-type="bibr" rid="B53">Eichelbaum and Krijgsveld, 2014</xref>). Stable isotope labeling of amino acids in cell culture (SILAC) has been combined with single-well solid phase-enhanced sample prep. Using this method, the newly produced proteome of isolated retinal axons was obtained rapidly (in approximately 5 min) (<xref ref-type="bibr" rid="B31">Cagnetta et al., 2018</xref>). Treating axons treated with stimuli such as netrin-1, brain-derived neurotropic factor, and Sema3A, has demonstrated distinct proteomes with more than 100 different nascent proteins. Compartment analysis using pulsed SILAC may be applied to ALS cells with a sophisticated culture device.</p>
<p>Using an axon-TRAP-RiboTag approach in mice, the dynamic translatome of axons in the retina <italic>in vivo</italic> matches the subcellular function (<xref ref-type="bibr" rid="B185">Shigeoka et al., 2016</xref>). The translatome of the embryonic and postnatal axons includes a changing, enriched set of genes with axon-specific roles. Thus, specific steps in axon wiring, such as axon growth, elimination of unnecessary axons, and synaptogenesis, may be present. Adult axons harbor a complicated translatome that plays a role in axon survival, neurotransmission, and neurodegenerative diseases. Mating of several ALS mouse models can help in precisely understanding mRNA dysregulation. Further transcriptome and proteome analyses using labeled growth cones of single projections in the mouse cerebral cortex <italic>in vivo</italic> may also be of use (<xref ref-type="bibr" rid="B163">Poulopoulos et al., 2019</xref>). Spatial transcriptomics is another method for elucidating gene expression in the mouse spinal cord over the disease course, and in postmortem tissue from patients with ALS (<xref ref-type="bibr" rid="B123">Maniatis et al., 2019</xref>). Another important approach is the single-cell transcriptomics of nerve organoids <italic>in vitro</italic> (<xref ref-type="bibr" rid="B167">Quadrato et al., 2017</xref>); pseudo-time analysis or single-cell trajectory analysis can help establish the relationship between the cause and effect of the transcriptome of the organoids (<xref ref-type="bibr" rid="B223">Xiang et al., 2017</xref>; <xref ref-type="bibr" rid="B104">Klaus et al., 2019</xref>). Sophisticated neuromuscular co-culture organoids would be beneficial for these studies.</p>
<p>Stimulated Raman scattering microscopy is a new technique for chemical imaging that can be used to map the distribution of various molecules–including lipids, proteins, and nucleic acids–in live cells and tissues, as determined by their intrinsic molecular vibration (<xref ref-type="bibr" rid="B60">Freudiger et al., 2008</xref>). The authors of this review used this type of imaging to visualize peripheral degeneration in several ALS mouse models and human postmortem tissue (<xref ref-type="bibr" rid="B204">Tian et al., 2016</xref>). Non-labeled live imaging of motor axons may assist in monitoring the time course of axonal pathology <italic>in vivo</italic>.</p>
<p>In clinical settings, the strength-duration time constant, which represents the hyperexcitability of an MN axon, is significantly increased in patients (<xref ref-type="bibr" rid="B92">Kanai et al., 2006</xref>, <xref ref-type="bibr" rid="B93">2012</xref>; <xref ref-type="bibr" rid="B64">Geevasinga et al., 2015</xref>). Hyperexcitability is thought to be the target of MN death in ALS (<xref ref-type="bibr" rid="B209">Wainger et al., 2014</xref>). In cell culture settings, the shortened isoform of TDP-43 is upregulated by neuronal hyperactivation (<xref ref-type="bibr" rid="B215">Weskamp et al., 2019</xref>). The role of these short isoform of TDP-43, which might be the product of dysregulation of RNA metabolism, should be considered in the axon fraction. Recent studies have revealed the importance of stathmin-2 (STMN2), a regulator of microtubule stability, in the pathomechanism of <italic>TARDBP</italic> mutation (<xref ref-type="bibr" rid="B105">Klim et al., 2019</xref>; <xref ref-type="bibr" rid="B128">Melamed et al., 2019</xref>). The expression of a microtubule regulator, <italic>STMN2</italic>, is decreased following <italic>TARDBP</italic> knockdown, when TDP-43 is mis-localized, and in MNs from patients and the spinal cord of postmortem samples. The reduced function of TDP-43 results in the loss of STMN2 due to altered splicing. This is functionally important, as STMN2 is necessary for the outgrowth and regeneration of MN axons. Post-translational STMN2 stabilization rescues neurite outgrowth and axon regeneration deficits by TDP-43 depletion (<xref ref-type="bibr" rid="B105">Klim et al., 2019</xref>). A reduction in TDP-43 inhibits axonal regeneration of iPSC-derived MNs, whereas rescue of the expression of STMN2 restores the axonal regeneration capacity (<xref ref-type="bibr" rid="B128">Melamed et al., 2019</xref>). The effect of the short form of TDP-43 or cryptic exons under the control of TDP-43 (<xref ref-type="bibr" rid="B115">Ling et al., 2015</xref>) should be examined in the axon fraction.</p>
</sec>
</sec>
<sec id="S4">
<title>Concluding Remarks</title>
<p>As described in the preceding section, advanced omics approaches, <italic>in vivo</italic> analysis, and axon–cytoplasmic interactions should be examined as the next steps in investigating axonal pathology in neurodegenerative disease research. The novel concept of microfluidic devices, including the nerve organoid device presented by the authors of this review, should be applied to other neuron types, co-culture systems, or proteomics analyses using human pluripotent cells, because this technique may help elucidate the resilience of long MN and the pathomechanism of ALS.</p>
</sec>
<sec id="S5">
<title>Author Contributions</title>
<p>NS, TA, and MA prepared the manuscript. All authors read, revised, and approved the final version of the manuscript.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MK declared a past co-authorship with the authors NS and MA to the handling Editor.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by funding from Grant-in-Aid for Young Scientists (A) (15H05667), Grant-in-Aid for Scientific Research (C) (18K07519), and Grant-in-Aid for Scientific Research (B) (16H05318) from Japanese Ministry of Education, Culture, Sports, Science and Technology; the Research Project for Practical Applications of Regenerative Medicine from the Japan Agency for Medical Research and Development (AMED) (Grant number 19bm0804003h0003); Japan Intractable Diseases (Nanbyo) Research Foundation, the Kanae Foundation for the Promotion of Medical Science, and “Inochi-no-Iro” ALS research grant.</p>
</fn>
</fn-group>
<ack>
<p>The authors thank H. Okano, T. Fujii, J. Kawada, S. Mitsuzawa, and K. Eggan for the excellent comments, Y. Akiyama for the illustrations. The authors also would like to thank Enago (<ext-link ext-link-type="uri" xlink:href="http://www.enago.jp">www.enago.jp</ext-link>) for the English language review.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackerley</surname><given-names>S.</given-names></name><name><surname>Grierson</surname><given-names>A. J.</given-names></name><name><surname>Banner</surname><given-names>S.</given-names></name><name><surname>Perkinton</surname><given-names>M. S.</given-names></name><name><surname>Brownlees</surname><given-names>J.</given-names></name><name><surname>Byers</surname><given-names>H. L.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>26</volume>
<fpage>354</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2004.02.009</pub-id>
<pub-id pub-id-type="pmid">15207859</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akins</surname><given-names>M. R.</given-names></name><name><surname>Leblanc</surname><given-names>H. F.</given-names></name><name><surname>Stackpole</surname><given-names>E. E.</given-names></name><name><surname>Chyung</surname><given-names>E.</given-names></name><name><surname>Fallon</surname><given-names>J. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>520</volume>
<fpage>3687</fpage>–<lpage>3706</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23123</pub-id>
<pub-id pub-id-type="pmid">22522693</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Fujimori</surname><given-names>K.</given-names></name><name><surname>Sone</surname><given-names>T.</given-names></name><name><surname>Kawada</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.</article-title>
<source/><italic>EBiomedicine</italic>
<volume>45</volume>
<fpage>362</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2019.06.013</pub-id>
<pub-id pub-id-type="pmid">31262712</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alami</surname><given-names>N. H.</given-names></name><name><surname>Smith</surname><given-names>R. B.</given-names></name><name><surname>Carrasco</surname><given-names>M. A.</given-names></name><name><surname>Williams</surname><given-names>L. A.</given-names></name><name><surname>Winborn</surname><given-names>C. S.</given-names></name><name><surname>Han</surname><given-names>S. S. W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations.</article-title>
<source/><italic>Neuron</italic>
<volume>81</volume>
<fpage>536</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.018</pub-id>
<pub-id pub-id-type="pmid">24507191</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allodi</surname><given-names>I.</given-names></name><name><surname>Nijssen</surname><given-names>J.</given-names></name><name><surname>Benitez</surname><given-names>J. A.</given-names></name><name><surname>Schweingruber</surname><given-names>C.</given-names></name><name><surname>Fuchs</surname><given-names>A.</given-names></name><name><surname>Bonvicini</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Modeling motor neuron resilience in ALS using stem cells.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>12</volume>
<fpage>1329</fpage>–<lpage>1341</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2019.04.009</pub-id>
<pub-id pub-id-type="pmid">31080111</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastasiadou</surname><given-names>S.</given-names></name><name><surname>Knoll</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>279</volume>
<fpage>243</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.03.012</pub-id>
<pub-id pub-id-type="pmid">26980486</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrusiak</surname><given-names>M. G.</given-names></name><name><surname>Sharifnia</surname><given-names>P.</given-names></name><name><surname>Lyu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Dickey</surname><given-names>A. M.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Inhibition of axon regeneration by liquid-like TIAR-2 granules.</article-title>
<source/><italic>Neuron</italic>
<volume>104</volume>
<fpage>290</fpage>–<lpage>304.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.07.004</pub-id>
<pub-id pub-id-type="pmid">31378567</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Ogasawara</surname><given-names>M.</given-names></name><name><surname>Matsubara</surname><given-names>Y.</given-names></name><name><surname>Narisawa</surname><given-names>K.</given-names></name><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Itoyama</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>Mild ALS in Japan associated with novel SOD mutation.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>5</volume>
<fpage>323</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1038/ng1293-323</pub-id>
<pub-id pub-id-type="pmid">8298637</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>G. A.</given-names></name><name><surname>Drapeau</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>4282</fpage>–<lpage>4292</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt278</pub-id>
<pub-id pub-id-type="pmid">23771027</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashley</surname><given-names>J.</given-names></name><name><surname>Cordy</surname><given-names>B.</given-names></name><name><surname>Lucia</surname><given-names>D.</given-names></name><name><surname>Fradkin</surname><given-names>L. G.</given-names></name><name><surname>Budnik</surname><given-names>V.</given-names></name><name><surname>Thomson</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Retrovirus-like gag protein Arc1 binds RNA and traffics across synaptic boutons.</article-title>
<source/><italic>Cell</italic>
<volume>172</volume>
<fpage>262</fpage>–<lpage>274.e11</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.12.022</pub-id>
<pub-id pub-id-type="pmid">29328915</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balendra</surname><given-names>R.</given-names></name><name><surname>Isaacs</surname><given-names>A. M.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>C9orf72</italic>-mediated ALS and FTD: multiple pathways to disease.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>14</volume>
<fpage>544</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-018-0047-2</pub-id>
<pub-id pub-id-type="pmid">30120348</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baleriola</surname><given-names>J.</given-names></name><name><surname>Walker</surname><given-names>C. A.</given-names></name><name><surname>Jean</surname><given-names>Y. Y.</given-names></name><name><surname>Crary</surname><given-names>J. F.</given-names></name><name><surname>Troy</surname><given-names>C. M.</given-names></name><name><surname>Nagy</surname><given-names>P. L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions.</article-title>
<source/><italic>Cell</italic>
<volume>158</volume>
<fpage>1159</fpage>–<lpage>1172</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.07.001</pub-id>
<pub-id pub-id-type="pmid">25171414</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassell</surname><given-names>G. J.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.</article-title>
<source/><italic>Neuron</italic>
<volume>60</volume>
<fpage>201</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.004</pub-id>
<pub-id pub-id-type="pmid">18957214</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>A. F.</given-names></name><name><surname>Hengst</surname><given-names>U.</given-names></name></person-group> (<year>2016</year>). <article-title>Intra-axonal protein synthesis in development and beyond.</article-title>
<source/><italic>Int. J. Dev. Neurosci.</italic>
<volume>55</volume>
<fpage>140</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2016.03.004</pub-id>
<pub-id pub-id-type="pmid">26970010</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Yaakov</surname><given-names>K.</given-names></name><name><surname>Dagan</surname><given-names>S. Y.</given-names></name><name><surname>Segal-Ruder</surname><given-names>Y.</given-names></name><name><surname>Shalem</surname><given-names>O.</given-names></name><name><surname>Vuppalanchi</surname><given-names>D.</given-names></name><name><surname>Willis</surname><given-names>D. E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Axonal transcription factors signal retrogradely in lesioned peripheral nerve.</article-title>
<source/><italic>EMBO J.</italic>
<volume>31</volume>
<fpage>1350</fpage>–<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.494</pub-id>
<pub-id pub-id-type="pmid">22246183</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergeron</surname><given-names>C.</given-names></name><name><surname>Beric-Maskarel</surname><given-names>K.</given-names></name><name><surname>Muntasser</surname><given-names>S.</given-names></name><name><surname>Weyer</surname><given-names>L.</given-names></name><name><surname>Somerville</surname><given-names>M. J.</given-names></name><name><surname>Percy</surname><given-names>M. E.</given-names></name></person-group> (<year>1994</year>). <article-title>Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>53</volume>
<fpage>221</fpage>–<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-199405000-00002</pub-id>
<pub-id pub-id-type="pmid">7909836</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard-Marissal</surname><given-names>N.</given-names></name><name><surname>Medard</surname><given-names>J. J.</given-names></name><name><surname>Azzedine</surname><given-names>H.</given-names></name><name><surname>Chrast</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration.</article-title>
<source/><italic>Brain</italic>
<volume>138</volume>
<fpage>875</fpage>–<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv008</pub-id>
<pub-id pub-id-type="pmid">25678561</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhinge</surname><given-names>A.</given-names></name><name><surname>Namboori</surname><given-names>S. C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Vandongen</surname><given-names>A. M. J.</given-names></name><name><surname>Stanton</surname><given-names>L. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>8</volume>
<fpage>856</fpage>–<lpage>869</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2017.02.019</pub-id>
<pub-id pub-id-type="pmid">28366453</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigler</surname><given-names>R. L.</given-names></name><name><surname>Kamande</surname><given-names>J. W.</given-names></name><name><surname>Dumitru</surname><given-names>R.</given-names></name><name><surname>Niedringhaus</surname><given-names>M.</given-names></name><name><surname>Taylor</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Messenger RNAs localized to distal projections of human stem cell derived neurons.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>611</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-00676-w</pub-id>
<pub-id pub-id-type="pmid">28377585</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boillee</surname><given-names>S.</given-names></name><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Lobsiger</surname><given-names>C. S.</given-names></name><name><surname>Copeland</surname><given-names>N. G.</given-names></name><name><surname>Jenkins</surname><given-names>N. A.</given-names></name><name><surname>Kassiotis</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Onset and progression in inherited ALS determined by motor neurons and microglia.</article-title>
<source/><italic>Science</italic>
<volume>312</volume>
<fpage>1389</fpage>–<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1126/science.1123511</pub-id>
<pub-id pub-id-type="pmid">16741123</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bommel</surname><given-names>H.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Rossoll</surname><given-names>W.</given-names></name><name><surname>Wiese</surname><given-names>S.</given-names></name><name><surname>Jablonka</surname><given-names>S.</given-names></name><name><surname>Boehm</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Missense mutation in the <italic>tubulin-specific chaperone E (Tbce)</italic> gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>159</volume>
<fpage>563</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200208001</pub-id>
<pub-id pub-id-type="pmid">12446740</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchelt</surname><given-names>D. R.</given-names></name><name><surname>Lee</surname><given-names>M. K.</given-names></name><name><surname>Slunt</surname><given-names>H. S.</given-names></name><name><surname>Guarnieri</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Z. S.</given-names></name><name><surname>Wong</surname><given-names>P. C.</given-names></name><etal></etal></person-group> (<year>1994</year>). <article-title>Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>91</volume>
<fpage>8292</fpage>–<lpage>8296</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.17.8292</pub-id>
<pub-id pub-id-type="pmid">8058797</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>S. T.</given-names></name><name><surname>Morfini</surname><given-names>G. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>105</volume>
<fpage>273</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2017.04.010</pub-id>
<pub-id pub-id-type="pmid">28411118</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>D.</given-names></name><name><surname>Muller</surname><given-names>K.</given-names></name><name><surname>Wieland</surname><given-names>T.</given-names></name><name><surname>Weydt</surname><given-names>P.</given-names></name><name><surname>Bohm</surname><given-names>S.</given-names></name><name><surname>Lule</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>NEK1 mutations in familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Brain</italic>
<volume>139</volume>:<issue>e28</issue>.</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>D.</given-names></name><name><surname>Yilmaz</surname><given-names>R.</given-names></name><name><surname>Muller</surname><given-names>K.</given-names></name><name><surname>Grehl</surname><given-names>T.</given-names></name><name><surname>Petri</surname><given-names>S.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Hot-spot KIF5A mutations cause familial ALS.</article-title>
<source/><italic>Brain</italic>
<volume>141</volume>
<fpage>688</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awx370</pub-id>
<pub-id pub-id-type="pmid">29342275</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brettschneider</surname><given-names>J.</given-names></name><name><surname>Petzold</surname><given-names>A.</given-names></name><name><surname>Sussmuth</surname><given-names>S. D.</given-names></name><name><surname>Ludolph</surname><given-names>A. C.</given-names></name><name><surname>Tumani</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Axonal damage markers in cerebrospinal fluid are increased in ALS.</article-title>
<source/><italic>Neurology</italic>
<volume>66</volume>
<fpage>852</fpage>–<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000203120.85850.54</pub-id>
<pub-id pub-id-type="pmid">16567701</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briese</surname><given-names>M.</given-names></name><name><surname>Saal</surname><given-names>L.</given-names></name><name><surname>Appenzeller</surname><given-names>S.</given-names></name><name><surname>Moradi</surname><given-names>M.</given-names></name><name><surname>Baluapuri</surname><given-names>A.</given-names></name><name><surname>Sendtner</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Whole transcriptome profiling reveals the RNA content of motor axons.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>44</volume>:<issue>e33</issue>. <pub-id pub-id-type="doi">10.1093/nar/gkv1027</pub-id>
<pub-id pub-id-type="pmid">26464439</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>R. H.</given-names><suffix>Jr.</suffix></name><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Amyotrophic lateral sclerosis.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>377</volume>:<issue>1602</issue>.</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryson</surname><given-names>J. B.</given-names></name><name><surname>Hobbs</surname><given-names>C.</given-names></name><name><surname>Parsons</surname><given-names>M. J.</given-names></name><name><surname>Bosch</surname><given-names>K. D.</given-names></name><name><surname>Pandraud</surname><given-names>A.</given-names></name><name><surname>Walsh</surname><given-names>F. S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>21</volume>
<fpage>3871</fpage>–<lpage>3882</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds215</pub-id>
<pub-id pub-id-type="pmid">22678056</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burberry</surname><given-names>A.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>J. Y.</given-names></name><name><surname>Moccia</surname><given-names>R.</given-names></name><name><surname>Mordes</surname><given-names>D. A.</given-names></name><name><surname>Stewart</surname><given-names>M. H.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Loss-of-function mutations in the <italic>C9ORF72</italic> mouse ortholog cause fatal autoimmune disease.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>8</volume>:<issue>347ra93</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf6038</pub-id>
<pub-id pub-id-type="pmid">27412785</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagnetta</surname><given-names>R.</given-names></name><name><surname>Frese</surname><given-names>C. K.</given-names></name><name><surname>Shigeoka</surname><given-names>T.</given-names></name><name><surname>Krijgsveld</surname><given-names>J.</given-names></name><name><surname>Holt</surname><given-names>C. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Rapid cue-specific remodeling of the nascent axonal proteome.</article-title>
<source/><italic>Neuron</italic>
<volume>99</volume>
<fpage>29</fpage>–<lpage>46.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.004</pub-id>
<pub-id pub-id-type="pmid">30008298</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>M. E.</given-names></name><name><surname>Walker</surname><given-names>D. M.</given-names></name><name><surname>Gancarz</surname><given-names>A. M.</given-names></name><name><surname>Wang</surname><given-names>Z. J.</given-names></name><name><surname>Lardner</surname><given-names>C. K.</given-names></name><name><surname>Bagot</surname><given-names>R. C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The dendritic spine morphogenic effects of repeated cocaine use occur through the regulation of serum response factor signaling.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>23</volume>
<fpage>1474</fpage>–<lpage>1486</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2017.116</pub-id>
<pub-id pub-id-type="pmid">28555077</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>K. A.</given-names></name><name><surname>Sheng</surname><given-names>Z. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Mechanisms for the maintenance and regulation of axonal energy supply.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>97</volume>
<fpage>897</fpage>–<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.24411</pub-id>
<pub-id pub-id-type="pmid">30883896</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chew</surname><given-names>J.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><name><surname>Prudencio</surname><given-names>M.</given-names></name><name><surname>Sasaguri</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y. J.</given-names></name><name><surname>Castanedes-Casey</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Neurodegeneration. <italic>C9ORF72</italic> repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits.</article-title>
<source/><italic>Science</italic>
<volume>348</volume>
<fpage>1151</fpage>–<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaa9344</pub-id>
<pub-id pub-id-type="pmid">25977373</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christie</surname><given-names>S. B.</given-names></name><name><surname>Akins</surname><given-names>M. R.</given-names></name><name><surname>Schwob</surname><given-names>J. E.</given-names></name><name><surname>Fallon</surname><given-names>J. R.</given-names></name></person-group> (<year>2009</year>). <article-title>The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>1514</fpage>–<lpage>1524</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3937-08.2009</pub-id>
<pub-id pub-id-type="pmid">19193898</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cioni</surname><given-names>J. M.</given-names></name><name><surname>Lin</surname><given-names>J. Q.</given-names></name><name><surname>Holtermann</surname><given-names>A. V.</given-names></name><name><surname>Koppers</surname><given-names>M.</given-names></name><name><surname>Jakobs</surname><given-names>M. A. H.</given-names></name><name><surname>Azizi</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Late endosomes act as mRNA translation platforms and sustain mitochondria in axons.</article-title>
<source/><italic>Cell</italic>
<volume>176</volume>
<fpage>56</fpage>–<lpage>72.e15</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.11.030</pub-id>
<pub-id pub-id-type="pmid">30612743</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Citterio</surname><given-names>A.</given-names></name><name><surname>Arnoldi</surname><given-names>A.</given-names></name><name><surname>Panzeri</surname><given-names>E.</given-names></name><name><surname>Merlini</surname><given-names>L.</given-names></name><name><surname>D’angelo</surname><given-names>M. G.</given-names></name><name><surname>Musumeci</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Variants in <italic>KIF1A</italic> gene in dominant and sporadic forms of hereditary spastic paraparesis.</article-title>
<source/><italic>J. Neurol.</italic>
<volume>262</volume>
<fpage>2684</fpage>–<lpage>2690</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-015-7899-9</pub-id>
<pub-id pub-id-type="pmid">26410750</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>C.</given-names></name><name><surname>Petrucelli</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Genetic convergence brings clarity to the enigmatic red line in ALS.</article-title>
<source/><italic>Neuron</italic>
<volume>101</volume>
<fpage>1057</fpage>–<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.032</pub-id>
<pub-id pub-id-type="pmid">30897357</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbo</surname><given-names>M.</given-names></name><name><surname>Hays</surname><given-names>A. P.</given-names></name></person-group> (<year>1992</year>). <article-title>Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>51</volume>
<fpage>531</fpage>–<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-199209000-00008</pub-id>
<pub-id pub-id-type="pmid">1381416</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosker</surname><given-names>K. E.</given-names></name><name><surname>Fenstermacher</surname><given-names>S. J.</given-names></name><name><surname>Pazyra-Murphy</surname><given-names>M. F.</given-names></name><name><surname>Elliott</surname><given-names>H. L.</given-names></name><name><surname>Segal</surname><given-names>R. A.</given-names></name></person-group> (<year>2016</year>). <article-title>The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>
<fpage>690</fpage>–<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4280</pub-id>
<pub-id pub-id-type="pmid">27019013</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crerar</surname><given-names>H.</given-names></name><name><surname>Scott-Solomon</surname><given-names>E.</given-names></name><name><surname>Bodkin-Clarke</surname><given-names>C.</given-names></name><name><surname>Andreassi</surname><given-names>C.</given-names></name><name><surname>Hazbon</surname><given-names>M.</given-names></name><name><surname>Logie</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Regulation of NGF signaling by an axonal untranslated mRNA.</article-title>
<source/><italic>Neuron</italic>
<volume>102</volume>
<fpage>553</fpage>–<lpage>563.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.011</pub-id>
<pub-id pub-id-type="pmid">30853298</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadon-Nachum</surname><given-names>M.</given-names></name><name><surname>Melamed</surname><given-names>E.</given-names></name><name><surname>Offen</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>The “dying-back” phenomenon of motor neurons in ALS.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>43</volume>
<fpage>470</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-010-9467-1</pub-id>
<pub-id pub-id-type="pmid">21057983</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>A. S.</given-names></name><name><surname>Koszka</surname><given-names>K.</given-names></name><name><surname>Kiskinis</surname><given-names>E.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Davis-Dusenbery</surname><given-names>B. N.</given-names></name><name><surname>Eggan</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Genetic validation of a therapeutic target in a mouse model of ALS.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>6</volume>:<issue>248ra104</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3009351</pub-id>
<pub-id pub-id-type="pmid">25100738</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vos</surname><given-names>K. J.</given-names></name><name><surname>Chapman</surname><given-names>A. L.</given-names></name><name><surname>Tennant</surname><given-names>M. E.</given-names></name><name><surname>Manser</surname><given-names>C.</given-names></name><name><surname>Tudor</surname><given-names>E. L.</given-names></name><name><surname>Lau</surname><given-names>K. F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>16</volume>
<fpage>2720</fpage>–<lpage>2728</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddm226</pub-id>
<pub-id pub-id-type="pmid">17725983</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Vos</surname><given-names>K. J.</given-names></name><name><surname>Hafezparast</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research?</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>105</volume>
<fpage>283</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2017.02.004</pub-id>
<pub-id pub-id-type="pmid">28235672</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deglincerti</surname><given-names>A.</given-names></name><name><surname>Jaffrey</surname><given-names>S. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Insights into the roles of local translation from the axonal transcriptome.</article-title>
<source/><italic>Open Biol.</italic>
<volume>2</volume>:<issue>120079</issue>. <pub-id pub-id-type="doi">10.1098/rsob.120079</pub-id>
<pub-id pub-id-type="pmid">22773949</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname><given-names>M.</given-names></name><name><surname>Mackenzie</surname><given-names>I. R.</given-names></name><name><surname>Boeve</surname><given-names>B. F.</given-names></name><name><surname>Boxer</surname><given-names>A. L.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Rutherford</surname><given-names>N. J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of <italic>C9ORF72</italic> causes chromosome 9p-linked FTD and ALS.</article-title>
<source/><italic>Neuron</italic>
<volume>72</volume>
<fpage>245</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id>
<pub-id pub-id-type="pmid">21944778</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denton</surname><given-names>K.</given-names></name><name><surname>Mou</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>C. C.</given-names></name><name><surname>Shah</surname><given-names>D.</given-names></name><name><surname>Chang</surname><given-names>J.</given-names></name><name><surname>Blackstone</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>27</volume>
<fpage>2517</fpage>–<lpage>2530</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy156</pub-id>
<pub-id pub-id-type="pmid">29726929</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Giorgio</surname><given-names>F. P.</given-names></name><name><surname>Carrasco</surname><given-names>M. A.</given-names></name><name><surname>Siao</surname><given-names>M. C.</given-names></name><name><surname>Maniatis</surname><given-names>T.</given-names></name><name><surname>Eggan</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>608</fpage>–<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1038/nn1885</pub-id>
<pub-id pub-id-type="pmid">17435754</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dormann</surname><given-names>D.</given-names></name><name><surname>Rodde</surname><given-names>R.</given-names></name><name><surname>Edbauer</surname><given-names>D.</given-names></name><name><surname>Bentmann</surname><given-names>E.</given-names></name><name><surname>Fischer</surname><given-names>I.</given-names></name><name><surname>Hruscha</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.</article-title>
<source/><italic>EMBO J.</italic>
<volume>29</volume>
<fpage>2841</fpage>–<lpage>2857</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2010.143</pub-id>
<pub-id pub-id-type="pmid">20606625</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebbing</surname><given-names>B.</given-names></name><name><surname>Mann</surname><given-names>K.</given-names></name><name><surname>Starosta</surname><given-names>A.</given-names></name><name><surname>Jaud</surname><given-names>J.</given-names></name><name><surname>Schols</surname><given-names>L.</given-names></name><name><surname>Schule</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>17</volume>
<fpage>1245</fpage>–<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn014</pub-id>
<pub-id pub-id-type="pmid">18203753</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edens</surname><given-names>B. M.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>N.</given-names></name><name><surname>Deng</surname><given-names>H. X.</given-names></name><name><surname>Siddique</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>Y. C.</given-names></name></person-group> (<year>2017</year>). <article-title>A novel ALS-associated variant in <italic>UBQLN4</italic> regulates motor axon morphogenesis.</article-title>
<source/><italic>eLife</italic>
<volume>6</volume>:<issue>e25453</issue>. <pub-id pub-id-type="doi">10.7554/eLife.25453</pub-id>
<pub-id pub-id-type="pmid">28463112</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichelbaum</surname><given-names>K.</given-names></name><name><surname>Krijgsveld</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Rapid temporal dynamics of transcription, protein synthesis, and secretion during macrophage activation.</article-title>
<source/><italic>Mol. Cell. Proteomics</italic>
<volume>13</volume>
<fpage>792</fpage>–<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M113.030916</pub-id>
<pub-id pub-id-type="pmid">24396086</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallini</surname><given-names>C.</given-names></name><name><surname>Donlin-Asp</surname><given-names>P. G.</given-names></name><name><surname>Rouanet</surname><given-names>J. P.</given-names></name><name><surname>Bassell</surname><given-names>G. J.</given-names></name><name><surname>Rossoll</surname><given-names>W.</given-names></name></person-group> (<year>2016</year>). <article-title>Deficiency of the survival of motor neuron protein impairs mRNA localization and local translation in the growth cone of motor neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>3811</fpage>–<lpage>3820</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2396-15.2016</pub-id>
<pub-id pub-id-type="pmid">27030765</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraiuolo</surname><given-names>L.</given-names></name><name><surname>Heath</surname><given-names>P. R.</given-names></name><name><surname>Holden</surname><given-names>H.</given-names></name><name><surname>Kasher</surname><given-names>P.</given-names></name><name><surname>Kirby</surname><given-names>J.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>9201</fpage>–<lpage>9219</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1470-07.2007</pub-id>
<pub-id pub-id-type="pmid">17715356</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraiuolo</surname><given-names>L.</given-names></name><name><surname>Kirby</surname><given-names>J.</given-names></name><name><surname>Grierson</surname><given-names>A. J.</given-names></name><name><surname>Sendtner</surname><given-names>M.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>7</volume>
<fpage>616</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2011.152</pub-id>
<pub-id pub-id-type="pmid">22051914</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fichera</surname><given-names>M.</given-names></name><name><surname>Lo Giudice</surname><given-names>M.</given-names></name><name><surname>Falco</surname><given-names>M.</given-names></name><name><surname>Sturnio</surname><given-names>M.</given-names></name><name><surname>Amata</surname><given-names>S.</given-names></name><name><surname>Calabrese</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia.</article-title>
<source/><italic>Neurology</italic>
<volume>63</volume>
<fpage>1108</fpage>–<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000138731.60693.d2</pub-id>
<pub-id pub-id-type="pmid">15452312</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fil</surname><given-names>D.</given-names></name><name><surname>Deloach</surname><given-names>A.</given-names></name><name><surname>Yadav</surname><given-names>S.</given-names></name><name><surname>Alkam</surname><given-names>D.</given-names></name><name><surname>Macnicol</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>686</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw429</pub-id>
<pub-id pub-id-type="pmid">28040732</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>L. R.</given-names></name><name><surname>Culver</surname><given-names>D. G.</given-names></name><name><surname>Tennant</surname><given-names>P.</given-names></name><name><surname>Davis</surname><given-names>A. A.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Castellano-Sanchez</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>185</volume>
<fpage>232</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2003.10.004</pub-id>
<pub-id pub-id-type="pmid">14736504</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freudiger</surname><given-names>C. W.</given-names></name><name><surname>Min</surname><given-names>W.</given-names></name><name><surname>Saar</surname><given-names>B. G.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Holtom</surname><given-names>G. R.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy.</article-title>
<source/><italic>Science</italic>
<volume>322</volume>
<fpage>1857</fpage>–<lpage>1861</lpage>. <pub-id pub-id-type="doi">10.1126/science.1165758</pub-id>
<pub-id pub-id-type="pmid">19095943</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frick</surname><given-names>P.</given-names></name><name><surname>Sellier</surname><given-names>C.</given-names></name><name><surname>Mackenzie</surname><given-names>I. R. A.</given-names></name><name><surname>Cheng</surname><given-names>C. Y.</given-names></name><name><surname>Tahraoui-Bories</surname><given-names>J.</given-names></name><name><surname>Martinat</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in <italic>C9orf72</italic> mutation carriers.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>6</volume>:<issue>72</issue>. <pub-id pub-id-type="doi">10.1186/s40478-018-0579-0</pub-id>
<pub-id pub-id-type="pmid">30075745</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimori</surname><given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>24</volume>
<fpage>1579</fpage>–<lpage>1589</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-018-0140-5</pub-id>
<pub-id pub-id-type="pmid">30127392</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>Y.</given-names></name><name><surname>Kaneko</surname><given-names>K.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Nukina</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>18664</fpage>–<lpage>18672</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.231209</pub-id>
<pub-id pub-id-type="pmid">21454603</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geevasinga</surname><given-names>N.</given-names></name><name><surname>Menon</surname><given-names>P.</given-names></name><name><surname>Howells</surname><given-names>J.</given-names></name><name><surname>Nicholson</surname><given-names>G. A.</given-names></name><name><surname>Kiernan</surname><given-names>M. C.</given-names></name><name><surname>Vucic</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Axonal ion channel dysfunction in <italic>C9orf72</italic> familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>JAMA Neurol.</italic>
<volume>72</volume>
<fpage>49</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2014.2940</pub-id>
<pub-id pub-id-type="pmid">25384182</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname><given-names>F.</given-names></name><name><surname>Scarlino</surname><given-names>S.</given-names></name><name><surname>Falzone</surname><given-names>Y. M.</given-names></name><name><surname>Lunetta</surname><given-names>C.</given-names></name><name><surname>Tremolizzo</surname><given-names>L.</given-names></name><name><surname>Quattrini</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>13</volume>:<issue>601</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2019.00601</pub-id>
<pub-id pub-id-type="pmid">31293369</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghasemi</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>R. H.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2018</year>). <article-title>Genetics of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Med.</italic>
<volume>8</volume>:<issue>a024125</issue>. <pub-id pub-id-type="doi">10.1101/cshperspect.a024125</pub-id>
<pub-id pub-id-type="pmid">28270533</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>K. L.</given-names></name><name><surname>Kalmar</surname><given-names>B.</given-names></name><name><surname>Rhymes</surname><given-names>E. R.</given-names></name><name><surname>Fellows</surname><given-names>A. D.</given-names></name><name><surname>Ahmed</surname><given-names>M.</given-names></name><name><surname>Whiting</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.</article-title>
<source/><italic>Cell Death Dis.</italic>
<volume>9</volume>:<issue>596</issue>. <pub-id pub-id-type="doi">10.1038/s41419-018-0624-8</pub-id>
<pub-id pub-id-type="pmid">29789529</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groen</surname><given-names>E. J.</given-names></name><name><surname>Fumoto</surname><given-names>K.</given-names></name><name><surname>Blokhuis</surname><given-names>A. M.</given-names></name><name><surname>Engelen-Lee</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Van Den Heuvel</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>3690</fpage>–<lpage>3704</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt222</pub-id>
<pub-id pub-id-type="pmid">23681068</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grueter</surname><given-names>B. A.</given-names></name><name><surname>Robison</surname><given-names>A. J.</given-names></name><name><surname>Neve</surname><given-names>R. L.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2013</year>). <article-title>FosB differentially modulates nucleus accumbens direct and indirect pathway function.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>1923</fpage>–<lpage>1928</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221742110</pub-id>
<pub-id pub-id-type="pmid">23319622</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumy</surname><given-names>L. F.</given-names></name><name><surname>Yeo</surname><given-names>G. S.</given-names></name><name><surname>Tung</surname><given-names>Y. C.</given-names></name><name><surname>Zivraj</surname><given-names>K. H.</given-names></name><name><surname>Willis</surname><given-names>D.</given-names></name><name><surname>Coppola</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization.</article-title>
<source/><italic>RNA</italic>
<volume>17</volume>
<fpage>85</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1261/rna.2386111</pub-id>
<pub-id pub-id-type="pmid">21098654</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Monaghan</surname><given-names>J.</given-names></name><name><surname>Freyermuth</surname><given-names>F.</given-names></name><name><surname>Sung</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains.</article-title>
<source/><italic>Cell</italic>
<volume>173</volume>
<fpage>677</fpage>–<lpage>692.e20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.002</pub-id>
<pub-id pub-id-type="pmid">29677512</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Naujock</surname><given-names>M.</given-names></name><name><surname>Fumagalli</surname><given-names>L.</given-names></name><name><surname>Vandoorne</surname><given-names>T.</given-names></name><name><surname>Baatsen</surname><given-names>P.</given-names></name><name><surname>Boon</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>861</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-00911-y</pub-id>
<pub-id pub-id-type="pmid">29021520</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadano</surname><given-names>S.</given-names></name><name><surname>Otomo</surname><given-names>A.</given-names></name><name><surname>Kunita</surname><given-names>R.</given-names></name><name><surname>Suzuki-Utsunomiya</surname><given-names>K.</given-names></name><name><surname>Akatsuka</surname><given-names>A.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.</article-title>
<source/><italic>PLoS One</italic>
<volume>5</volume>:<issue>e9805</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0009805</pub-id>
<pub-id pub-id-type="pmid">20339559</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>J. E.</given-names></name><name><surname>Madison</surname><given-names>D. V.</given-names></name></person-group> (<year>2007</year>). <article-title>Presynaptic FMR1 genotype influences the degree of synaptic connectivity in a mosaic mouse model of fragile X syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>4014</fpage>–<lpage>4018</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4717-06.2007</pub-id>
<pub-id pub-id-type="pmid">17428978</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Bai</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>N.</given-names></name><name><surname>White</surname><given-names>N. M.</given-names></name><name><surname>Lauer</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.</article-title>
<source/><italic>Nature</italic>
<volume>526</volume>
<fpage>710</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1038/nature15510</pub-id>
<pub-id pub-id-type="pmid">26503042</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>K.</given-names></name><name><surname>Lim</surname><given-names>S. M.</given-names></name><name><surname>Nahm</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>Y. E.</given-names></name><name><surname>Oh</surname><given-names>K. W.</given-names></name><name><surname>Park</surname><given-names>H. T.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A <italic>de novo RAPGEF2</italic> variant identified in a sporadic amyotrophic lateral sclerosis patient impairs microtubule stability and axonal mitochondria distribution.</article-title>
<source/><italic>Exp. Neurobiol.</italic>
<volume>27</volume>
<fpage>550</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.5607/en.2018.27.6.550</pub-id>
<pub-id pub-id-type="pmid">30636905</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>A.</given-names></name><name><surname>Donnenfeld</surname><given-names>H.</given-names></name><name><surname>Sasaki</surname><given-names>S.</given-names></name><name><surname>Nakano</surname><given-names>I.</given-names></name></person-group> (<year>1984a</year>). <article-title>Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>43</volume>
<fpage>461</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-198409000-00001</pub-id>
<pub-id pub-id-type="pmid">6540799</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>A.</given-names></name><name><surname>Nakano</surname><given-names>I.</given-names></name><name><surname>Kurland</surname><given-names>L. T.</given-names></name><name><surname>Mulder</surname><given-names>D. W.</given-names></name><name><surname>Holley</surname><given-names>P. W.</given-names></name><name><surname>Saccomanno</surname><given-names>G.</given-names></name></person-group> (<year>1984b</year>). <article-title>Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>43</volume>
<fpage>471</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-198409000-00002</pub-id>
<pub-id pub-id-type="pmid">6540800</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofweber</surname><given-names>M.</given-names></name><name><surname>Hutten</surname><given-names>S.</given-names></name><name><surname>Bourgeois</surname><given-names>B.</given-names></name><name><surname>Spreitzer</surname><given-names>E.</given-names></name><name><surname>Niedner-Boblenz</surname><given-names>A.</given-names></name><name><surname>Schifferer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation.</article-title>
<source/><italic>Cell</italic>
<volume>173</volume>
<fpage>706</fpage>–<lpage>719.e13</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.004</pub-id>
<pub-id pub-id-type="pmid">29677514</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>A. L.</given-names></name><name><surname>Don</surname><given-names>E. K.</given-names></name><name><surname>Rayner</surname><given-names>S. L.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Laird</surname><given-names>A. S.</given-names></name><name><surname>Watchon</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>2616</fpage>–<lpage>2626</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx136</pub-id>
<pub-id pub-id-type="pmid">28444311</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howland</surname><given-names>D. S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>She</surname><given-names>Y.</given-names></name><name><surname>Goad</surname><given-names>B.</given-names></name><name><surname>Maragakis</surname><given-names>N. J.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>99</volume>
<fpage>1604</fpage>–<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.032539299</pub-id>
<pub-id pub-id-type="pmid">11818550</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichiyanagi</surname><given-names>N.</given-names></name><name><surname>Fujimori</surname><given-names>K.</given-names></name><name><surname>Yano</surname><given-names>M.</given-names></name><name><surname>Ishihara-Fujisaki</surname><given-names>C.</given-names></name><name><surname>Sone</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Establishment of in vitro FUS-associated familial amyotrophic lateral sclerosis model using human induced pluripotent stem cells.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>6</volume>
<fpage>496</fpage>–<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2016.02.011</pub-id>
<pub-id pub-id-type="pmid">26997647</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>Y.</given-names></name><name><surname>Ofengeim</surname><given-names>D.</given-names></name><name><surname>Najafov</surname><given-names>A.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Saberi</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.</article-title>
<source/><italic>Science</italic>
<volume>353</volume>
<fpage>603</fpage>–<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf6803</pub-id>
<pub-id pub-id-type="pmid">27493188</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>S. J.</given-names></name><name><surname>Jaffrey</surname><given-names>S. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Axonal transcription factors: novel regulators of growth cone-to-nucleus signaling.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>74</volume>
<fpage>245</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22112</pub-id>
<pub-id pub-id-type="pmid">23897628</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><name><surname>Saberi</surname><given-names>S.</given-names></name><name><surname>Mcalonis-Downes</surname><given-names>M.</given-names></name><name><surname>Seelman</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Gain of toxicity from ALS/FTD-linked repeat expansions in <italic>C9ORF72</italic> is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs.</article-title>
<source/><italic>Neuron</italic>
<volume>90</volume>
<fpage>535</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.006</pub-id>
<pub-id pub-id-type="pmid">27112497</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y. M.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><name><surname>Yoshihara</surname><given-names>T.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Terao</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>57</volume>
<fpage>236</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20379</pub-id>
<pub-id pub-id-type="pmid">15668976</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>J. O.</given-names></name><name><surname>Mandrioli</surname><given-names>J.</given-names></name><name><surname>Benatar</surname><given-names>M.</given-names></name><name><surname>Abramzon</surname><given-names>Y.</given-names></name><name><surname>Van Deerlin</surname><given-names>V. M.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Exome sequencing reveals VCP mutations as a cause of familial ALS.</article-title>
<source/><italic>Neuron</italic>
<volume>68</volume>
<fpage>857</fpage>–<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.036</pub-id>
<pub-id pub-id-type="pmid">21145000</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joung</surname><given-names>J. K.</given-names></name><name><surname>Sander</surname><given-names>J. D.</given-names></name></person-group> (<year>2013</year>). <article-title>TALENs: a widely applicable technology for targeted genome editing.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>14</volume>
<fpage>49</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3486</pub-id>
<pub-id pub-id-type="pmid">23169466</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>H.</given-names></name><name><surname>Yoon</surname><given-names>B. C.</given-names></name><name><surname>Holt</surname><given-names>C. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>13</volume>
<fpage>308</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3210</pub-id>
<pub-id pub-id-type="pmid">22498899</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabashi</surname><given-names>E.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Tradewell</surname><given-names>M. L.</given-names></name><name><surname>Dion</surname><given-names>P. A.</given-names></name><name><surname>Bercier</surname><given-names>V.</given-names></name><name><surname>Bourgouin</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>19</volume>
<fpage>671</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp534</pub-id>
<pub-id pub-id-type="pmid">19959528</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabashi</surname><given-names>E.</given-names></name><name><surname>Valdmanis</surname><given-names>P. N.</given-names></name><name><surname>Dion</surname><given-names>P.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Mcconkey</surname><given-names>B. J.</given-names></name><name><surname>Vande Velde</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>40</volume>
<fpage>572</fpage>–<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1038/ng.132</pub-id>
<pub-id pub-id-type="pmid">18372902</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanai</surname><given-names>K.</given-names></name><name><surname>Kuwabara</surname><given-names>S.</given-names></name><name><surname>Misawa</surname><given-names>S.</given-names></name><name><surname>Tamura</surname><given-names>N.</given-names></name><name><surname>Ogawara</surname><given-names>K.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.</article-title>
<source/><italic>Brain</italic>
<volume>129</volume>
<fpage>953</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awl024</pub-id>
<pub-id pub-id-type="pmid">16467388</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanai</surname><given-names>K.</given-names></name><name><surname>Shibuya</surname><given-names>K.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Misawa</surname><given-names>S.</given-names></name><name><surname>Nasu</surname><given-names>S.</given-names></name><name><surname>Sekiguchi</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>83</volume>
<fpage>734</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2011-301782</pub-id>
<pub-id pub-id-type="pmid">22566594</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S. H.</given-names></name><name><surname>Fukaya</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>J. K.</given-names></name><name><surname>Rothstein</surname><given-names>J. D.</given-names></name><name><surname>Bergles</surname><given-names>D. E.</given-names></name></person-group> (<year>2010</year>). <article-title>NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration.</article-title>
<source/><italic>Neuron</italic>
<volume>68</volume>
<fpage>668</fpage>–<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.009</pub-id>
<pub-id pub-id-type="pmid">21092857</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S. H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Fukaya</surname><given-names>M.</given-names></name><name><surname>Lorenzini</surname><given-names>I.</given-names></name><name><surname>Cleveland</surname><given-names>D. W.</given-names></name><name><surname>Ostrow</surname><given-names>L. W.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>16</volume>
<fpage>571</fpage>–<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3357</pub-id>
<pub-id pub-id-type="pmid">23542689</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapeli</surname><given-names>K.</given-names></name><name><surname>Martinez</surname><given-names>F. J.</given-names></name><name><surname>Yeo</surname><given-names>G. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic mutations in RNA-binding proteins and their roles in ALS.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>136</volume>
<fpage>1193</fpage>–<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-017-1830-7</pub-id>
<pub-id pub-id-type="pmid">28762175</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawada</surname><given-names>J.</given-names></name><name><surname>Kaneda</surname><given-names>S.</given-names></name><name><surname>Kirihara</surname><given-names>T.</given-names></name><name><surname>Maroof</surname><given-names>A.</given-names></name><name><surname>Levi</surname><given-names>T.</given-names></name><name><surname>Eggan</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Generation of a motor nerve organoid with human stem cell-derived neurons.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>9</volume>
<fpage>1441</fpage>–<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2017.09.021</pub-id>
<pub-id pub-id-type="pmid">29107592</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelleher</surname><given-names>R. J.</given-names><suffix>III</suffix></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2008</year>). <article-title>The autistic neuron: troubled translation?</article-title>
<source/><italic>Cell</italic>
<volume>135</volume>
<fpage>401</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.10.017</pub-id>
<pub-id pub-id-type="pmid">18984149</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenna</surname><given-names>K. P.</given-names></name><name><surname>Van Doormaal</surname><given-names>P. T.</given-names></name><name><surname>Dekker</surname><given-names>A. M.</given-names></name><name><surname>Ticozzi</surname><given-names>N.</given-names></name><name><surname>Kenna</surname><given-names>B. J.</given-names></name><name><surname>Diekstra</surname><given-names>F. P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>48</volume>
<fpage>1037</fpage>–<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3626</pub-id>
<pub-id pub-id-type="pmid">27455347</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieran</surname><given-names>D.</given-names></name><name><surname>Woods</surname><given-names>I.</given-names></name><name><surname>Villunger</surname><given-names>A.</given-names></name><name><surname>Strasser</surname><given-names>A.</given-names></name><name><surname>Prehn</surname><given-names>J. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>20606</fpage>–<lpage>20611</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707906105</pub-id>
<pub-id pub-id-type="pmid">18077368</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>H.</given-names></name><name><surname>Almer</surname><given-names>G.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Guegan</surname><given-names>C.</given-names></name><name><surname>Nagai</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>6025</fpage>–<lpage>6030</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0509227103</pub-id>
<pub-id pub-id-type="pmid">16595634</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Taylor</surname><given-names>J. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Lost in transportation: nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases.</article-title>
<source/><italic>Neuron</italic>
<volume>96</volume>
<fpage>285</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.029</pub-id>
<pub-id pub-id-type="pmid">29024655</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiryu-Seo</surname><given-names>S.</given-names></name><name><surname>Kiyama</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Mitochondrial behavior during axon regeneration/degeneration in vivo.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>139</volume>
<fpage>42</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2018.08.014</pub-id>
<pub-id pub-id-type="pmid">30179641</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaus</surname><given-names>J.</given-names></name><name><surname>Kanton</surname><given-names>S.</given-names></name><name><surname>Kyrousi</surname><given-names>C.</given-names></name><name><surname>Ayo-Martin</surname><given-names>A. C.</given-names></name><name><surname>Di Giaimo</surname><given-names>R.</given-names></name><name><surname>Riesenberg</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Altered neuronal migratory trajectories in human cerebral organoids derived from individuals with neuronal heterotopia.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>25</volume>
<fpage>561</fpage>–<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-019-0371-0</pub-id>
<pub-id pub-id-type="pmid">30858616</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klim</surname><given-names>J. R.</given-names></name><name><surname>Williams</surname><given-names>L. A.</given-names></name><name><surname>Limone</surname><given-names>F.</given-names></name><name><surname>Guerra San Juan</surname><given-names>I.</given-names></name><name><surname>Davis-Dusenbery</surname><given-names>B. N.</given-names></name><name><surname>Mordes</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>22</volume>
<fpage>167</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0300-4</pub-id>
<pub-id pub-id-type="pmid">30643292</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>T. J.</given-names><suffix>Jr.</suffix></name><name><surname>Bosco</surname><given-names>D. A.</given-names></name><name><surname>Leclerc</surname><given-names>A. L.</given-names></name><name><surname>Tamrazian</surname><given-names>E.</given-names></name><name><surname>Vanderburg</surname><given-names>C. R.</given-names></name><name><surname>Russ</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Science</italic>
<volume>323</volume>
<fpage>1205</fpage>–<lpage>1208</lpage>. <pub-id pub-id-type="doi">10.1126/science.1166066</pub-id>
<pub-id pub-id-type="pmid">19251627</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>I.</given-names></name><name><surname>Xiang</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Theodoropoulos</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Poly-dipeptides encoded by the <italic>C9orf72</italic> repeats bind nucleoli, impede RNA biogenesis, and kill cells.</article-title>
<source/><italic>Science</italic>
<volume>345</volume>
<fpage>1139</fpage>–<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1126/science.1254917</pub-id>
<pub-id pub-id-type="pmid">25081482</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kye</surname><given-names>M. J.</given-names></name><name><surname>Niederst</surname><given-names>E. D.</given-names></name><name><surname>Wertz</surname><given-names>M. H.</given-names></name><name><surname>Goncalves Ido</surname><given-names>C.</given-names></name><name><surname>Akten</surname><given-names>B.</given-names></name><name><surname>Dover</surname><given-names>K. Z.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>SMN regulates axonal local translation via miR-183/mTOR pathway.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>6318</fpage>–<lpage>6331</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu350</pub-id>
<pub-id pub-id-type="pmid">25055867</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafragette</surname><given-names>A.</given-names></name><name><surname>Bardo</surname><given-names>M. T.</given-names></name><name><surname>Lardeux</surname><given-names>V.</given-names></name><name><surname>Solinas</surname><given-names>M.</given-names></name><name><surname>Thiriet</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Reduction of cocaine-induced locomotor effects by enriched environment is associated with cell-specific accumulation of DeltaFosB in striatal and cortical subregions.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>20</volume>
<fpage>237</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1093/ijnp/pyw097</pub-id>
<pub-id pub-id-type="pmid">27815415</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laird</surname><given-names>A. S.</given-names></name><name><surname>Van Hoecke</surname><given-names>A.</given-names></name><name><surname>De Muynck</surname><given-names>L.</given-names></name><name><surname>Timmers</surname><given-names>M.</given-names></name><name><surname>Van Den Bosch</surname><given-names>L.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.</article-title>
<source/><italic>PLoS One</italic>
<volume>5</volume>:<issue>e13368</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0013368</pub-id>
<pub-id pub-id-type="pmid">20967127</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Morrison</surname><given-names>B. M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lengacher</surname><given-names>S.</given-names></name><name><surname>Farah</surname><given-names>M. H.</given-names></name><name><surname>Hoffman</surname><given-names>P. N.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Oligodendroglia metabolically support axons and contribute to neurodegeneration.</article-title>
<source/><italic>Nature</italic>
<volume>487</volume>
<fpage>443</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1038/nature11314</pub-id>
<pub-id pub-id-type="pmid">22801498</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>12708</issue>. <pub-id pub-id-type="doi">10.1038/ncomms12708</pub-id>
<pub-id pub-id-type="pmid">27620379</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y. C.</given-names></name><name><surname>Fernandopulle</surname><given-names>M. S.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Hao</surname><given-names>L.</given-names></name><name><surname>Drerup</surname><given-names>C. M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether.</article-title>
<source/><italic>Cell</italic>
<volume>179</volume>
<fpage>147</fpage>–<lpage>164.e20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.08.050</pub-id>
<pub-id pub-id-type="pmid">31539493</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M. Y.</given-names></name><name><surname>Cheng</surname><given-names>X. T.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Cai</surname><given-names>Q.</given-names></name><name><surname>Sheng</surname><given-names>Z. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Removing dysfunctional mitochondria from axons independent of mitophagy under pathophysiological conditions.</article-title>
<source/><italic>Autophagy</italic>
<volume>13</volume>
<fpage>1792</fpage>–<lpage>1794</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2017.1356552</pub-id>
<pub-id pub-id-type="pmid">28812939</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>J. P.</given-names></name><name><surname>Pletnikova</surname><given-names>O.</given-names></name><name><surname>Troncoso</surname><given-names>J. C.</given-names></name><name><surname>Wong</surname><given-names>P. C.</given-names></name></person-group> (<year>2015</year>). <article-title>TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.</article-title>
<source/><italic>Science</italic>
<volume>349</volume>
<fpage>650</fpage>–<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1126/science.aab0983</pub-id>
<pub-id pub-id-type="pmid">26250685</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Erauskin</surname><given-names>J.</given-names></name><name><surname>Tadokoro</surname><given-names>T.</given-names></name><name><surname>Baughn</surname><given-names>M. W.</given-names></name><name><surname>Myers</surname><given-names>B.</given-names></name><name><surname>Mcalonis-Downes</surname><given-names>M.</given-names></name><name><surname>Chillon-Marinas</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS.</article-title>
<source/><italic>Neuron</italic>
<volume>100</volume>
<fpage>816</fpage>–<lpage>830.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.09.044</pub-id>
<pub-id pub-id-type="pmid">30344044</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciel</surname><given-names>R.</given-names></name><name><surname>Bis</surname><given-names>D. M.</given-names></name><name><surname>Rebelo</surname><given-names>A. P.</given-names></name><name><surname>Saghira</surname><given-names>C.</given-names></name><name><surname>Zuchner</surname><given-names>S.</given-names></name><name><surname>Saporta</surname><given-names>M. A.</given-names></name></person-group> (<year>2018</year>). <article-title>The human motor neuron axonal transcriptome is enriched for transcripts related to mitochondrial function and microtubule-based axonal transport.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>307</volume>
<fpage>155</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2018.06.008</pub-id>
<pub-id pub-id-type="pmid">29935168</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>I. R.</given-names></name><name><surname>Nicholson</surname><given-names>A. M.</given-names></name><name><surname>Sarkar</surname><given-names>M.</given-names></name><name><surname>Messing</surname><given-names>J.</given-names></name><name><surname>Purice</surname><given-names>M. D.</given-names></name><name><surname>Pottier</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics.</article-title>
<source/><italic>Neuron</italic>
<volume>95</volume>
<fpage>808</fpage>–<lpage>816.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.07.025</pub-id>
<pub-id pub-id-type="pmid">28817800</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>I. R.</given-names></name><name><surname>Rademakers</surname><given-names>R.</given-names></name><name><surname>Neumann</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>9</volume>
<fpage>995</fpage>–<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70195-2</pub-id>
<pub-id pub-id-type="pmid">20864052</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname><given-names>S.</given-names></name><name><surname>Holzbaur</surname><given-names>E. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Compartment-specific regulation of autophagy in primary neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>5933</fpage>–<lpage>5945</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4401-15.2016</pub-id>
<pub-id pub-id-type="pmid">27251616</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maday</surname><given-names>S.</given-names></name><name><surname>Twelvetrees</surname><given-names>A. E.</given-names></name><name><surname>Moughamian</surname><given-names>A. J.</given-names></name><name><surname>Holzbaur</surname><given-names>E. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Axonal transport: cargo-specific mechanisms of motility and regulation.</article-title>
<source/><italic>Neuron</italic>
<volume>84</volume>
<fpage>292</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.10.019</pub-id>
<pub-id pub-id-type="pmid">25374356</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrane</surname><given-names>J.</given-names></name><name><surname>Cortez</surname><given-names>C.</given-names></name><name><surname>Gan</surname><given-names>W. B.</given-names></name><name><surname>Manfredi</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>1413</fpage>–<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt528</pub-id>
<pub-id pub-id-type="pmid">24154542</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maniatis</surname><given-names>S.</given-names></name><name><surname>Aijo</surname><given-names>T.</given-names></name><name><surname>Vickovic</surname><given-names>S.</given-names></name><name><surname>Braine</surname><given-names>C.</given-names></name><name><surname>Kang</surname><given-names>K.</given-names></name><name><surname>Mollbrink</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Science</italic>
<volume>364</volume>
<fpage>89</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1126/science.aav9776</pub-id>
<pub-id pub-id-type="pmid">30948552</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>N.</given-names></name><name><surname>Jaubert</surname><given-names>J.</given-names></name><name><surname>Gounon</surname><given-names>P.</given-names></name><name><surname>Salido</surname><given-names>E.</given-names></name><name><surname>Haase</surname><given-names>G.</given-names></name><name><surname>Szatanik</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>A missense mutation in <italic>Tbce</italic> causes progressive motor neuronopathy in mice.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>32</volume>
<fpage>443</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1038/ng1016</pub-id>
<pub-id pub-id-type="pmid">12389029</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>E.</given-names></name><name><surname>Di Polo</surname><given-names>A.</given-names></name><name><surname>Vande Velde</surname><given-names>C.</given-names></name><name><surname>Robitaille</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS.</article-title>
<source/><italic>eLife</italic>
<volume>7</volume>:<issue>e41973</issue>. <pub-id pub-id-type="doi">10.7554/eLife.41973</pub-id>
<pub-id pub-id-type="pmid">30320556</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>H.</given-names></name><name><surname>Morino</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>H.</given-names></name><name><surname>Izumi</surname><given-names>Y.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Watanabe</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mutations of optineurin in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nature</italic>
<volume>465</volume>
<fpage>223</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1038/nature08971</pub-id>
<pub-id pub-id-type="pmid">20428114</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWhorter</surname><given-names>M. L.</given-names></name><name><surname>Monani</surname><given-names>U. R.</given-names></name><name><surname>Burghes</surname><given-names>A. H.</given-names></name><name><surname>Beattie</surname><given-names>C. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>162</volume>
<fpage>919</fpage>–<lpage>931</lpage>. <pub-id pub-id-type="pmid">12952942</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname><given-names>Z.</given-names></name><name><surname>Lopez-Erauskin</surname><given-names>J.</given-names></name><name><surname>Baughn</surname><given-names>M. W.</given-names></name><name><surname>Zhang</surname><given-names>O.</given-names></name><name><surname>Drenner</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>22</volume>
<fpage>180</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0293-z</pub-id>
<pub-id pub-id-type="pmid">30643298</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>S.</given-names></name><name><surname>Gupton</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Recent advances in branching mechanisms underlying neuronal morphogenesis.</article-title>
<source/><italic>F1000Res.</italic>
<volume>7</volume>:F1000 Faculty Rev-1779.</mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merianda</surname><given-names>T. T.</given-names></name><name><surname>Lin</surname><given-names>A. C.</given-names></name><name><surname>Lam</surname><given-names>J. S.</given-names></name><name><surname>Vuppalanchi</surname><given-names>D.</given-names></name><name><surname>Willis</surname><given-names>D. E.</given-names></name><name><surname>Karin</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A functional equivalent of endoplasmic reticulum and Golgi in axons for secretion of locally synthesized proteins.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>40</volume>
<fpage>128</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2008.09.008</pub-id>
<pub-id pub-id-type="pmid">19022387</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millecamps</surname><given-names>S.</given-names></name><name><surname>Julien</surname><given-names>J. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Axonal transport deficits and neurodegenerative diseases.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>14</volume>
<fpage>161</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3380</pub-id>
<pub-id pub-id-type="pmid">23361386</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname><given-names>S.</given-names></name><name><surname>Gronke</surname><given-names>S.</given-names></name><name><surname>Niccoli</surname><given-names>T.</given-names></name><name><surname>Ridler</surname><given-names>C. E.</given-names></name><name><surname>Clayton</surname><given-names>E. L.</given-names></name><name><surname>Devoy</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title><italic>C9orf72</italic> repeat expansions cause neurodegeneration in <italic>Drosophila</italic> through arginine-rich proteins.</article-title>
<source/><italic>Science</italic>
<volume>345</volume>
<fpage>1192</fpage>–<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1126/science.1256800</pub-id>
<pub-id pub-id-type="pmid">25103406</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moller</surname><given-names>A.</given-names></name><name><surname>Bauer</surname><given-names>C. S.</given-names></name><name><surname>Cohen</surname><given-names>R. N.</given-names></name><name><surname>Webster</surname><given-names>C. P.</given-names></name><name><surname>De Vos</surname><given-names>K. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>4668</fpage>–<lpage>4679</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx348</pub-id>
<pub-id pub-id-type="pmid">28973175</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moloney</surname><given-names>E. B.</given-names></name><name><surname>De Winter</surname><given-names>F.</given-names></name><name><surname>Verhaagen</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>8</volume>:<issue>252</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2014.00252</pub-id>
<pub-id pub-id-type="pmid">25177267</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>M.</given-names></name><name><surname>Sivadasan</surname><given-names>R.</given-names></name><name><surname>Saal</surname><given-names>L.</given-names></name><name><surname>Luningschror</surname><given-names>P.</given-names></name><name><surname>Dombert</surname><given-names>B.</given-names></name><name><surname>Rathod</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Differential roles of alpha-, beta-, and gamma-actin in axon growth and collateral branch formation in motoneurons.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>216</volume>
<fpage>793</fpage>–<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201604117</pub-id>
<pub-id pub-id-type="pmid">28246119</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K.</given-names></name><name><surname>Weng</surname><given-names>S. M.</given-names></name><name><surname>Arzberger</surname><given-names>T.</given-names></name><name><surname>May</surname><given-names>S.</given-names></name><name><surname>Rentzsch</surname><given-names>K.</given-names></name><name><surname>Kremmer</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The <italic>C9orf72</italic> GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.</article-title>
<source/><italic>Science</italic>
<volume>339</volume>
<fpage>1335</fpage>–<lpage>1338</lpage>. <pub-id pub-id-type="doi">10.1126/science.1232927</pub-id>
<pub-id pub-id-type="pmid">23393093</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morisaki</surname><given-names>T.</given-names></name><name><surname>Lyon</surname><given-names>K.</given-names></name><name><surname>Deluca</surname><given-names>K. F.</given-names></name><name><surname>Deluca</surname><given-names>J. G.</given-names></name><name><surname>English</surname><given-names>B. P.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Real-time quantification of single RNA translation dynamics in living cells.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>
<fpage>1425</fpage>–<lpage>1429</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf0899</pub-id>
<pub-id pub-id-type="pmid">27313040</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrice</surname><given-names>J. R.</given-names></name><name><surname>Gregory-Evans</surname><given-names>C. Y.</given-names></name><name><surname>Shaw</surname><given-names>C. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Modeling environmentally-induced motor neuron degeneration in zebrafish.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>8</volume>:<issue>4890</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-23018-w</pub-id>
<pub-id pub-id-type="pmid">29559645</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>B. M.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Rothstein</surname><given-names>J. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Oligodendroglia: metabolic supporters of axons.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>23</volume>
<fpage>644</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2013.07.007</pub-id>
<pub-id pub-id-type="pmid">23988427</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munch</surname><given-names>C.</given-names></name><name><surname>Sedlmeier</surname><given-names>R.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Homberg</surname><given-names>V.</given-names></name><name><surname>Sperfeld</surname><given-names>A. D.</given-names></name><name><surname>Kurt</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.</article-title>
<source/><italic>Neurology</italic>
<volume>63</volume>
<fpage>724</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000134608.83927.b1</pub-id>
<pub-id pub-id-type="pmid">15326253</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>M.</given-names></name><name><surname>Re</surname><given-names>D. B.</given-names></name><name><surname>Nagata</surname><given-names>T.</given-names></name><name><surname>Chalazonitis</surname><given-names>A.</given-names></name><name><surname>Jessell</surname><given-names>T. M.</given-names></name><name><surname>Wichterle</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>615</fpage>–<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1038/nn1876</pub-id>
<pub-id pub-id-type="pmid">17435755</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakazawa</surname><given-names>S.</given-names></name><name><surname>Oikawa</surname><given-names>D.</given-names></name><name><surname>Ishii</surname><given-names>R.</given-names></name><name><surname>Ayaki</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>12547</issue>. <pub-id pub-id-type="doi">10.1038/ncomms12547</pub-id>
<pub-id pub-id-type="pmid">27552911</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naumann</surname><given-names>M.</given-names></name><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Goswami</surname><given-names>A.</given-names></name><name><surname>Lojewski</surname><given-names>X.</given-names></name><name><surname>Japtok</surname><given-names>J.</given-names></name><name><surname>Vehlow</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>335</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-02299-1</pub-id>
<pub-id pub-id-type="pmid">29362359</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedelsky</surname><given-names>N. B.</given-names></name><name><surname>Taylor</surname><given-names>J. P.</given-names></name></person-group> (<year>2019</year>). <article-title>Bridging biophysics and neurology: aberrant phase transitions in neurodegenerative disease.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>15</volume>
<fpage>272</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-019-0157-5</pub-id>
<pub-id pub-id-type="pmid">30890779</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neto</surname><given-names>E.</given-names></name><name><surname>Leitao</surname><given-names>L.</given-names></name><name><surname>Sousa</surname><given-names>D. M.</given-names></name><name><surname>Alves</surname><given-names>C. J.</given-names></name><name><surname>Alencastre</surname><given-names>I. S.</given-names></name><name><surname>Aguiar</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Compartmentalized microfluidic platforms: the unrivaled breakthrough of in vitro tools for neurobiological research.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>11573</fpage>–<lpage>11584</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1748-16.2016</pub-id>
<pub-id pub-id-type="pmid">27852766</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>A.</given-names></name><name><surname>Kenna</surname><given-names>K. P.</given-names></name><name><surname>Renton</surname><given-names>A. E.</given-names></name><name><surname>Ticozzi</surname><given-names>N.</given-names></name><name><surname>Faghri</surname><given-names>F.</given-names></name><name><surname>Chia</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Genome-wide analyses identify KIF5A as a novel ALS gene.</article-title>
<source/><italic>Neuron</italic>
<volume>97</volume>
<fpage>1268</fpage>–<lpage>1283.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.02.027</pub-id>
<pub-id pub-id-type="pmid">29566793</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijssen</surname><given-names>J.</given-names></name><name><surname>Aguila</surname><given-names>J.</given-names></name><name><surname>Hoogstraaten</surname><given-names>R.</given-names></name><name><surname>Kee</surname><given-names>N.</given-names></name><name><surname>Hedlund</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Axon-Seq decodes the motor axon transcriptome and its modulation in response to ALS.</article-title>
<source/><italic>Stem Cell Rep.</italic>
<volume>11</volume>
<fpage>1565</fpage>–<lpage>1578</lpage>. <pub-id pub-id-type="doi">10.1016/j.stemcr.2018.11.005</pub-id>
<pub-id pub-id-type="pmid">30540963</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijssen</surname><given-names>J.</given-names></name><name><surname>Comley</surname><given-names>L. H.</given-names></name><name><surname>Hedlund</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>133</volume>
<fpage>863</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-017-1708-8</pub-id>
<pub-id pub-id-type="pmid">28409282</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>A.</given-names></name><name><surname>Niihori</surname><given-names>T.</given-names></name><name><surname>Warita</surname><given-names>H.</given-names></name><name><surname>Izumi</surname><given-names>R.</given-names></name><name><surname>Akiyama</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>53</volume>
<fpage>e191</fpage>–<lpage>e194</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.01.004</pub-id>
<pub-id pub-id-type="pmid">28160950</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonaka</surname><given-names>T.</given-names></name><name><surname>Masuda-Suzukake</surname><given-names>M.</given-names></name><name><surname>Arai</surname><given-names>T.</given-names></name><name><surname>Hasegawa</surname><given-names>Y.</given-names></name><name><surname>Akatsu</surname><given-names>H.</given-names></name><name><surname>Obi</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Prion-like properties of pathological TDP-43 aggregates from diseased brains.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>4</volume>
<fpage>124</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.06.007</pub-id>
<pub-id pub-id-type="pmid">23831027</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>Y.</given-names></name><name><surname>Yamazaki</surname><given-names>H.</given-names></name><name><surname>Sekine-Aizawa</surname><given-names>Y.</given-names></name><name><surname>Hirokawa</surname><given-names>N.</given-names></name></person-group> (<year>1995</year>). <article-title>The neuron-specific kinesin superfamily protein <italic>KIF1A</italic> is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors.</article-title>
<source/><italic>Cell</italic>
<volume>81</volume>
<fpage>769</fpage>–<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90538-3</pub-id>
<pub-id pub-id-type="pmid">7539720</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okano</surname><given-names>H.</given-names></name><name><surname>Yamanaka</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>iPS cell technologies: significance and applications to CNS regeneration and disease.</article-title>
<source/><italic>Mol. Brain</italic>
<volume>7</volume>:<issue>22</issue>. <pub-id pub-id-type="doi">10.1186/1756-6606-7-22</pub-id>
<pub-id pub-id-type="pmid">24685317</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Rourke</surname><given-names>J. G.</given-names></name><name><surname>Bogdanik</surname><given-names>L.</given-names></name><name><surname>Yanez</surname><given-names>A.</given-names></name><name><surname>Lall</surname><given-names>D.</given-names></name><name><surname>Wolf</surname><given-names>A. J.</given-names></name><name><surname>Muhammad</surname><given-names>A. K.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title><italic>C9orf72</italic> is required for proper macrophage and microglial function in mice.</article-title>
<source/><italic>Science</italic>
<volume>351</volume>
<fpage>1324</fpage>–<lpage>1329</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf1064</pub-id>
<pub-id pub-id-type="pmid">26989253</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osking</surname><given-names>Z.</given-names></name><name><surname>Ayers</surname><given-names>J. I.</given-names></name><name><surname>Hildebrandt</surname><given-names>R.</given-names></name><name><surname>Skruber</surname><given-names>K.</given-names></name><name><surname>Brown</surname><given-names>H.</given-names></name><name><surname>Ryu</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>ALS-linked SOD1 mutants enhance neurite outgrowth and branching in adult motor neurons.</article-title>
<source/><italic>iScience</italic>
<volume>11</volume>
<fpage>294</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2018.12.026</pub-id>
<pub-id pub-id-type="pmid">30639851</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parras</surname><given-names>A.</given-names></name><name><surname>Anta</surname><given-names>H.</given-names></name><name><surname>Santos-Galindo</surname><given-names>M.</given-names></name><name><surname>Swarup</surname><given-names>V.</given-names></name><name><surname>Elorza</surname><given-names>A.</given-names></name><name><surname>Nieto-Gonzalez</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing.</article-title>
<source/><italic>Nature</italic>
<volume>560</volume>
<fpage>441</fpage>–<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0423-5</pub-id>
<pub-id pub-id-type="pmid">30111840</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>M. J.</given-names></name><name><surname>Hullinger</surname><given-names>R.</given-names></name><name><surname>O’riordan</surname><given-names>K. J.</given-names></name><name><surname>Burger</surname><given-names>C.</given-names></name><name><surname>Pehar</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Improved proteostasis in the secretory pathway rescues Alzheimer’s disease in the mouse.</article-title>
<source/><italic>Brain</italic>
<volume>139</volume>
<fpage>937</fpage>–<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv385</pub-id>
<pub-id pub-id-type="pmid">26787453</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereno</surname><given-names>G. L.</given-names></name><name><surname>Balaszczuk</surname><given-names>V.</given-names></name><name><surname>Beltramino</surname><given-names>C. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Kainic acid-induced early genes activation and neuronal death in the medial extended amygdala of rats.</article-title>
<source/><italic>Exp. Toxicol. Pathol.</italic>
<volume>63</volume>
<fpage>291</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.etp.2010.02.001</pub-id>
<pub-id pub-id-type="pmid">20185282</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>O. M.</given-names></name><name><surname>Cabrera</surname><given-names>G. T.</given-names></name><name><surname>Tran</surname><given-names>H.</given-names></name><name><surname>Gendron</surname><given-names>T. F.</given-names></name><name><surname>Mckeon</surname><given-names>J. E.</given-names></name><name><surname>Metterville</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Human <italic>C9ORF72</italic> hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice.</article-title>
<source/><italic>Neuron</italic>
<volume>88</volume>
<fpage>902</fpage>–<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.11.018</pub-id>
<pub-id pub-id-type="pmid">26637797</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philips</surname><given-names>T.</given-names></name><name><surname>Bento-Abreu</surname><given-names>A.</given-names></name><name><surname>Nonneman</surname><given-names>A.</given-names></name><name><surname>Haeck</surname><given-names>W.</given-names></name><name><surname>Staats</surname><given-names>K.</given-names></name><name><surname>Geelen</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Brain</italic>
<volume>136</volume>
<fpage>471</fpage>–<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aws339</pub-id>
<pub-id pub-id-type="pmid">23378219</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picchiarelli</surname><given-names>G.</given-names></name><name><surname>Demestre</surname><given-names>M.</given-names></name><name><surname>Zuko</surname><given-names>A.</given-names></name><name><surname>Been</surname><given-names>M.</given-names></name><name><surname>Higelin</surname><given-names>J.</given-names></name><name><surname>Dieterle</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>22</volume>
<fpage>1793</fpage>–<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-019-0498-9</pub-id>
<pub-id pub-id-type="pmid">31591561</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plachta</surname><given-names>N.</given-names></name><name><surname>Annaheim</surname><given-names>C.</given-names></name><name><surname>Bissiere</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Ruegg</surname><given-names>M.</given-names></name><name><surname>Hoving</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>712</fpage>–<lpage>719</lpage>. <pub-id pub-id-type="doi">10.1038/nn1897</pub-id>
<pub-id pub-id-type="pmid">17486104</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porta</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Restrepo</surname><given-names>C. R.</given-names></name><name><surname>Kwong</surname><given-names>L. K.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Brown</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>4220</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-06548-9</pub-id>
<pub-id pub-id-type="pmid">30310141</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulopoulos</surname><given-names>A.</given-names></name><name><surname>Murphy</surname><given-names>A. J.</given-names></name><name><surname>Ozkan</surname><given-names>A.</given-names></name><name><surname>Davis</surname><given-names>P.</given-names></name><name><surname>Hatch</surname><given-names>J.</given-names></name><name><surname>Kirchner</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Subcellular transcriptomes and proteomes of developing axon projections in the cerebral cortex.</article-title>
<source/><italic>Nature</italic>
<volume>565</volume>
<fpage>356</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0847-y</pub-id>
<pub-id pub-id-type="pmid">30626971</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradat</surname><given-names>P. F.</given-names></name><name><surname>Bruneteau</surname><given-names>G.</given-names></name><name><surname>Gonzalez De Aguilar</surname><given-names>J. L.</given-names></name><name><surname>Dupuis</surname><given-names>L.</given-names></name><name><surname>Jokic</surname><given-names>N.</given-names></name><name><surname>Salachas</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>62</volume>
<fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21122</pub-id>
<pub-id pub-id-type="pmid">17455292</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puls</surname><given-names>I.</given-names></name><name><surname>Jonnakuty</surname><given-names>C.</given-names></name><name><surname>Lamonte</surname><given-names>B. H.</given-names></name><name><surname>Holzbaur</surname><given-names>E. L.</given-names></name><name><surname>Tokito</surname><given-names>M.</given-names></name><name><surname>Mann</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutant dynactin in motor neuron disease.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>33</volume>
<fpage>455</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="pmid">12627231</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qamar</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Randle</surname><given-names>S. J.</given-names></name><name><surname>Ruggeri</surname><given-names>F. S.</given-names></name><name><surname>Varela</surname><given-names>J. A.</given-names></name><name><surname>Lin</surname><given-names>J. Q.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions.</article-title>
<source/><italic>Cell</italic>
<volume>173</volume>
<fpage>720</fpage>–<lpage>734.e15</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.056</pub-id>
<pub-id pub-id-type="pmid">29677515</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quadrato</surname><given-names>G.</given-names></name><name><surname>Nguyen</surname><given-names>T.</given-names></name><name><surname>Macosko</surname><given-names>E. Z.</given-names></name><name><surname>Sherwood</surname><given-names>J. L.</given-names></name><name><surname>Min Yang</surname><given-names>S.</given-names></name><name><surname>Berger</surname><given-names>D. R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Cell diversity and network dynamics in photosensitive human brain organoids.</article-title>
<source/><italic>Nature</italic>
<volume>545</volume>
<fpage>48</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nature22047</pub-id>
<pub-id pub-id-type="pmid">28445462</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rage</surname><given-names>F.</given-names></name><name><surname>Boulisfane</surname><given-names>N.</given-names></name><name><surname>Rihan</surname><given-names>K.</given-names></name><name><surname>Neel</surname><given-names>H.</given-names></name><name><surname>Gostan</surname><given-names>T.</given-names></name><name><surname>Bertrand</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization.</article-title>
<source/><italic>RNA</italic>
<volume>19</volume>
<fpage>1755</fpage>–<lpage>1766</lpage>. <pub-id pub-id-type="doi">10.1261/rna.040204.113</pub-id>
<pub-id pub-id-type="pmid">24152552</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname><given-names>A. E.</given-names></name><name><surname>Majounie</surname><given-names>E.</given-names></name><name><surname>Waite</surname><given-names>A.</given-names></name><name><surname>Simon-Sanchez</surname><given-names>J.</given-names></name><name><surname>Rollinson</surname><given-names>S.</given-names></name><name><surname>Gibbs</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>A hexanucleotide repeat expansion in <italic>C9ORF72</italic> is the cause of chromosome 9p21-linked ALS-FTD.</article-title>
<source/><italic>Neuron</italic>
<volume>72</volume>
<fpage>257</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id>
<pub-id pub-id-type="pmid">21944779</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>N.</given-names></name><name><surname>Clarelli</surname><given-names>F.</given-names></name><name><surname>Domi</surname><given-names>T.</given-names></name><name><surname>Cerri</surname><given-names>F.</given-names></name><name><surname>Gallia</surname><given-names>F.</given-names></name><name><surname>Trimarco</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>39297</issue>. <pub-id pub-id-type="doi">10.1038/srep39297</pub-id>
<pub-id pub-id-type="pmid">27982123</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>D. R.</given-names></name><name><surname>Siddique</surname><given-names>T.</given-names></name><name><surname>Patterson</surname><given-names>D.</given-names></name><name><surname>Figlewicz</surname><given-names>D. A.</given-names></name><name><surname>Sapp</surname><given-names>P.</given-names></name><name><surname>Hentati</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nature</italic>
<volume>362</volume>
<fpage>59</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="pmid">8446170</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotem</surname><given-names>N.</given-names></name><name><surname>Magen</surname><given-names>I.</given-names></name><name><surname>Ionescu</surname><given-names>A.</given-names></name><name><surname>Gershoni-Emek</surname><given-names>N.</given-names></name><name><surname>Altman</surname><given-names>T.</given-names></name><name><surname>Costa</surname><given-names>C. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ALS along the axons - expression of coding and noncoding RNA differs in axons of ALS models.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>44500</issue>. <pub-id pub-id-type="doi">10.1038/srep44500</pub-id>
<pub-id pub-id-type="pmid">28300211</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouleau</surname><given-names>G. A.</given-names></name><name><surname>Clark</surname><given-names>A. W.</given-names></name><name><surname>Rooke</surname><given-names>K.</given-names></name><name><surname>Pramatarova</surname><given-names>A.</given-names></name><name><surname>Krizus</surname><given-names>A.</given-names></name><name><surname>Suchowersky</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>39</volume>
<fpage>128</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="pmid">8572658</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>V. M.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name></person-group> (<year>2005</year>). <article-title>Axonal transport defects: a common theme in neurodegenerative diseases.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>109</volume>
<fpage>5</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-004-0952-x</pub-id>
<pub-id pub-id-type="pmid">15645263</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutherford</surname><given-names>N. J.</given-names></name><name><surname>Zhang</surname><given-names>Y. J.</given-names></name><name><surname>Baker</surname><given-names>M.</given-names></name><name><surname>Gass</surname><given-names>J. M.</given-names></name><name><surname>Finch</surname><given-names>N. A.</given-names></name><name><surname>Xu</surname><given-names>Y. F.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>4</volume>:<issue>e1000193</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000193</pub-id>
<pub-id pub-id-type="pmid">18802454</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saal</surname><given-names>L.</given-names></name><name><surname>Briese</surname><given-names>M.</given-names></name><name><surname>Kneitz</surname><given-names>S.</given-names></name><name><surname>Glinka</surname><given-names>M.</given-names></name><name><surname>Sendtner</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Subcellular transcriptome alterations in a cell culture model of spinal muscular atrophy point to widespread defects in axonal growth and presynaptic differentiation.</article-title>
<source/><italic>RNA</italic>
<volume>20</volume>
<fpage>1789</fpage>–<lpage>1802</lpage>. <pub-id pub-id-type="doi">10.1261/rna.047373.114</pub-id>
<pub-id pub-id-type="pmid">25246652</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabari</surname><given-names>B. R.</given-names></name><name><surname>Dall’agnese</surname><given-names>A.</given-names></name><name><surname>Boija</surname><given-names>A.</given-names></name><name><surname>Klein</surname><given-names>I. A.</given-names></name><name><surname>Coffey</surname><given-names>E. L.</given-names></name><name><surname>Shrinivas</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Coactivator condensation at super-enhancers links phase separation and gene control.</article-title>
<source/><italic>Science</italic>
<volume>361</volume>:<issue>eaar3958</issue>. <pub-id pub-id-type="doi">10.1126/science.aar3958</pub-id>
<pub-id pub-id-type="pmid">29930091</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvadores</surname><given-names>N.</given-names></name><name><surname>Sanhueza</surname><given-names>M.</given-names></name><name><surname>Manque</surname><given-names>P.</given-names></name><name><surname>Court</surname><given-names>F. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Axonal degeneration during aging and its functional role in neurodegenerative disorders.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>451</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00451</pub-id>
<pub-id pub-id-type="pmid">28928628</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambandan</surname><given-names>S.</given-names></name><name><surname>Akbalik</surname><given-names>G.</given-names></name><name><surname>Kochen</surname><given-names>L.</given-names></name><name><surname>Rinne</surname><given-names>J.</given-names></name><name><surname>Kahlstatt</surname><given-names>J.</given-names></name><name><surname>Glock</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Activity-dependent spatially localized miRNA maturation in neuronal dendrites.</article-title>
<source/><italic>Science</italic>
<volume>355</volume>
<fpage>634</fpage>–<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf8995</pub-id>
<pub-id pub-id-type="pmid">28183980</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scekic-Zahirovic</surname><given-names>J.</given-names></name><name><surname>Sendscheid</surname><given-names>O.</given-names></name><name><surname>El Oussini</surname><given-names>H.</given-names></name><name><surname>Jambeau</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Mersmann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.</article-title>
<source/><italic>EMBO J.</italic>
<volume>35</volume>
<fpage>1077</fpage>–<lpage>1097</lpage>. <pub-id pub-id-type="doi">10.15252/embj.201592559</pub-id>
<pub-id pub-id-type="pmid">26951610</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>N.</given-names></name><name><surname>Akaaboune</surname><given-names>M.</given-names></name><name><surname>Gajendran</surname><given-names>N.</given-names></name><name><surname>Martinez-Pena</surname><given-names>Y.</given-names></name><name><surname>Valenzuela</surname><given-names>I.</given-names></name><name><surname>Wakefield</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of alpha-dystrobrevin.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>195</volume>
<fpage>1171</fpage>–<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201107083</pub-id>
<pub-id pub-id-type="pmid">22184199</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoen</surname><given-names>M.</given-names></name><name><surname>Reichel</surname><given-names>J. M.</given-names></name><name><surname>Demestre</surname><given-names>M.</given-names></name><name><surname>Putz</surname><given-names>S.</given-names></name><name><surname>Deshpande</surname><given-names>D.</given-names></name><name><surname>Proepper</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Super-resolution microscopy reveals presynaptic localization of the ALS/FTD related protein FUS in hippocampal neurons.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>496</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00496</pub-id>
<pub-id pub-id-type="pmid">26834559</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>Z.</given-names></name><name><surname>Noh</surname><given-names>H.</given-names></name><name><surname>Bin Kim</surname><given-names>W.</given-names></name><name><surname>Ni</surname><given-names>P.</given-names></name><name><surname>Nguyen</surname><given-names>C.</given-names></name><name><surname>Cote</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>22</volume>
<fpage>229</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0313-z</pub-id>
<pub-id pub-id-type="pmid">30664768</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Lyashchenko</surname><given-names>A. K.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Nasrabady</surname><given-names>S. E.</given-names></name><name><surname>Elmaleh</surname><given-names>M.</given-names></name><name><surname>Mendelsohn</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>10465</issue>. <pub-id pub-id-type="doi">10.1038/ncomms10465</pub-id>
<pub-id pub-id-type="pmid">26842965</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shigeoka</surname><given-names>T.</given-names></name><name><surname>Jung</surname><given-names>H.</given-names></name><name><surname>Jung</surname><given-names>J.</given-names></name><name><surname>Turner-Bridger</surname><given-names>B.</given-names></name><name><surname>Ohk</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>J. Q.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Dynamic axonal translation in developing and mature visual circuits.</article-title>
<source/><italic>Cell</italic>
<volume>166</volume>
<fpage>181</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.029</pub-id>
<pub-id pub-id-type="pmid">27321671</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiihashi</surname><given-names>G.</given-names></name><name><surname>Ito</surname><given-names>D.</given-names></name><name><surname>Yagi</surname><given-names>T.</given-names></name><name><surname>Nihei</surname><given-names>Y.</given-names></name><name><surname>Ebine</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice.</article-title>
<source/><italic>Brain</italic>
<volume>139</volume>
<fpage>2380</fpage>–<lpage>2394</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww161</pub-id>
<pub-id pub-id-type="pmid">27368346</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivadasan</surname><given-names>R.</given-names></name><name><surname>Hornburg</surname><given-names>D.</given-names></name><name><surname>Drepper</surname><given-names>C.</given-names></name><name><surname>Frank</surname><given-names>N.</given-names></name><name><surname>Jablonka</surname><given-names>S.</given-names></name><name><surname>Hansel</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title><italic>C9ORF72</italic> interaction with cofilin modulates actin dynamics in motor neurons.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>
<fpage>1610</fpage>–<lpage>1618</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4407</pub-id>
<pub-id pub-id-type="pmid">27723745</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>B. N.</given-names></name><name><surname>Ticozzi</surname><given-names>N.</given-names></name><name><surname>Fallini</surname><given-names>C.</given-names></name><name><surname>Gkazi</surname><given-names>A. S.</given-names></name><name><surname>Topp</surname><given-names>S.</given-names></name><name><surname>Kenna</surname><given-names>K. P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.</article-title>
<source/><italic>Neuron</italic>
<volume>84</volume>
<fpage>324</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.09.027</pub-id>
<pub-id pub-id-type="pmid">25374358</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>B. N.</given-names></name><name><surname>Topp</surname><given-names>S. D.</given-names></name><name><surname>Fallini</surname><given-names>C.</given-names></name><name><surname>Shibata</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>H. J.</given-names></name><name><surname>Troakes</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>9</volume>:<issue>eaad9157</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aad9157</pub-id>
<pub-id pub-id-type="pmid">28469040</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>E.</given-names></name><name><surname>Mitchell</surname><given-names>J. C.</given-names></name><name><surname>Memmi</surname><given-names>C.</given-names></name><name><surname>Chennell</surname><given-names>G.</given-names></name><name><surname>Vizcay-Barrena</surname><given-names>G.</given-names></name><name><surname>Allison</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>27</volume>
<fpage>463</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx415</pub-id>
<pub-id pub-id-type="pmid">29194538</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaulding</surname><given-names>E. L.</given-names></name><name><surname>Burgess</surname><given-names>R. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Accumulating evidence for axonal translation in neuronal homeostasis.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>312</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00312</pub-id>
<pub-id pub-id-type="pmid">28620277</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillane</surname><given-names>M.</given-names></name><name><surname>Ketschek</surname><given-names>A.</given-names></name><name><surname>Merianda</surname><given-names>T. T.</given-names></name><name><surname>Twiss</surname><given-names>J. L.</given-names></name><name><surname>Gallo</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondria coordinate sites of axon branching through localized intra-axonal protein synthesis.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>5</volume>
<fpage>1564</fpage>–<lpage>1575</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.11.022</pub-id>
<pub-id pub-id-type="pmid">24332852</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinacker</surname><given-names>P.</given-names></name><name><surname>Feneberg</surname><given-names>E.</given-names></name><name><surname>Weishaupt</surname><given-names>J.</given-names></name><name><surname>Brettschneider</surname><given-names>J.</given-names></name><name><surname>Tumani</surname><given-names>H.</given-names></name><name><surname>Andersen</surname><given-names>P. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>87</volume>
<fpage>12</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2015-311387</pub-id>
<pub-id pub-id-type="pmid">26296871</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storkebaum</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Peripheral neuropathy via mutant tRNA synthetases: inhibition of protein translation provides a possible explanation.</article-title>
<source/><italic>Bioessays</italic>
<volume>38</volume>
<fpage>818</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1002/bies.201600052</pub-id>
<pub-id pub-id-type="pmid">27352040</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Warita</surname><given-names>H.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Mizuno</surname><given-names>H.</given-names></name><name><surname>Shimakura</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion.</article-title>
<source/><italic>J. Hum. Genet.</italic>
<volume>55</volume>
<fpage>252</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2010.16</pub-id>
<pub-id pub-id-type="pmid">20224596</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliaferro</surname><given-names>P.</given-names></name><name><surname>Burke</surname><given-names>R. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Retrograde axonal degeneration in Parkinson disease.</article-title>
<source/><italic>J. Parkinsons Dis.</italic>
<volume>6</volume>
<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3233/JPD-150769</pub-id>
<pub-id pub-id-type="pmid">27003783</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>H.</given-names></name><name><surname>Kimura</surname><given-names>M.</given-names></name><name><surname>Nagahara</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Kawasaki</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>170</volume>
<fpage>341</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12277</pub-id>
<pub-id pub-id-type="pmid">23763343</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>A.</given-names></name><name><surname>Iida</surname><given-names>K.</given-names></name><name><surname>Tsubota</surname><given-names>T.</given-names></name><name><surname>Hosokawa</surname><given-names>M.</given-names></name><name><surname>Denawa</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>J. B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Loss of Sfpq causes long-gene transcriptopathy in the brain.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>23</volume>
<fpage>1326</fpage>–<lpage>1341</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.141</pub-id>
<pub-id pub-id-type="pmid">29719248</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tashiro</surname><given-names>Y.</given-names></name><name><surname>Urushitani</surname><given-names>M.</given-names></name><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Uchiyama</surname><given-names>Y.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>287</volume>
<fpage>42984</fpage>–<lpage>42994</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.417600</pub-id>
<pub-id pub-id-type="pmid">23095749</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>A. M.</given-names></name><name><surname>Berchtold</surname><given-names>N. C.</given-names></name><name><surname>Perreau</surname><given-names>V. M.</given-names></name><name><surname>Tu</surname><given-names>C. H.</given-names></name><name><surname>Li Jeon</surname><given-names>N.</given-names></name><name><surname>Cotman</surname><given-names>C. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Axonal mRNA in uninjured and regenerating cortical mammalian axons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>4697</fpage>–<lpage>4707</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6130-08.2009</pub-id>
<pub-id pub-id-type="pmid">19369540</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tcherkezian</surname><given-names>J.</given-names></name><name><surname>Brittis</surname><given-names>P. A.</given-names></name><name><surname>Thomas</surname><given-names>F.</given-names></name><name><surname>Roux</surname><given-names>P. P.</given-names></name><name><surname>Flanagan</surname><given-names>J. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation.</article-title>
<source/><italic>Cell</italic>
<volume>141</volume>
<fpage>632</fpage>–<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.04.008</pub-id>
<pub-id pub-id-type="pmid">20434207</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiel</surname><given-names>C.</given-names></name><name><surname>Kessler</surname><given-names>K.</given-names></name><name><surname>Giessl</surname><given-names>A.</given-names></name><name><surname>Dimmler</surname><given-names>A.</given-names></name><name><surname>Shalev</surname><given-names>S. A.</given-names></name><name><surname>Von Der Haar</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>NEK1 mutations cause short-rib polydactyly syndrome type Majewski.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>88</volume>
<fpage>106</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.12.004</pub-id>
<pub-id pub-id-type="pmid">21211617</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas-Jinu</surname><given-names>S.</given-names></name><name><surname>Gordon</surname><given-names>P. M.</given-names></name><name><surname>Fielding</surname><given-names>T.</given-names></name><name><surname>Taylor</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>B. N.</given-names></name><name><surname>Snowden</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Non-nuclear pool of splicing factor SFPQ regulates axonal transcripts required for normal motor development.</article-title>
<source/><italic>Neuron</italic>
<volume>94</volume>
<fpage>322</fpage>–<lpage>336.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.026</pub-id>
<pub-id pub-id-type="pmid">28392072</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Mordes</surname><given-names>D. A.</given-names></name><name><surname>Wang</surname><given-names>J. Y.</given-names></name><name><surname>Salameh</surname><given-names>J. S.</given-names></name><name><surname>Mok</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>13283</issue>. <pub-id pub-id-type="doi">10.1038/ncomms13283</pub-id>
<pub-id pub-id-type="pmid">27796305</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urushitani</surname><given-names>M.</given-names></name><name><surname>Ezzi</surname><given-names>S. A.</given-names></name><name><surname>Matsuo</surname><given-names>A.</given-names></name><name><surname>Tooyama</surname><given-names>I.</given-names></name><name><surname>Julien</surname><given-names>J. P.</given-names></name></person-group> (<year>2008</year>). <article-title>The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS.</article-title>
<source/><italic>FASEB J.</italic>
<volume>22</volume>
<fpage>2476</fpage>–<lpage>2487</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-092783</pub-id>
<pub-id pub-id-type="pmid">18337461</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vance</surname><given-names>C.</given-names></name><name><surname>Rogelj</surname><given-names>B.</given-names></name><name><surname>Hortobagyi</surname><given-names>T.</given-names></name><name><surname>De Vos</surname><given-names>K. J.</given-names></name><name><surname>Nishimura</surname><given-names>A. L.</given-names></name><name><surname>Sreedharan</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.</article-title>
<source/><italic>Science</italic>
<volume>323</volume>
<fpage>1208</fpage>–<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1126/science.1165942</pub-id>
<pub-id pub-id-type="pmid">19251628</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkova</surname><given-names>K.</given-names></name><name><surname>Christov</surname><given-names>A.</given-names></name><name><surname>Kamaluddin</surname><given-names>Z.</given-names></name><name><surname>Kobalka</surname><given-names>P.</given-names></name><name><surname>Siddiqui</surname><given-names>S.</given-names></name><name><surname>Hensley</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1G93A mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>73</volume>
<fpage>702</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0000000000000086</pub-id>
<pub-id pub-id-type="pmid">24918638</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verheijen</surname><given-names>M. H.</given-names></name><name><surname>Peviani</surname><given-names>M.</given-names></name><name><surname>Hendricusdottir</surname><given-names>R.</given-names></name><name><surname>Bell</surname><given-names>E. M.</given-names></name><name><surname>Lammens</surname><given-names>M.</given-names></name><name><surname>Smit</surname><given-names>A. B.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Increased axonal ribosome numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e87255</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0087255</pub-id>
<pub-id pub-id-type="pmid">24498056</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wainger</surname><given-names>B. J.</given-names></name><name><surname>Kiskinis</surname><given-names>E.</given-names></name><name><surname>Mellin</surname><given-names>C.</given-names></name><name><surname>Wiskow</surname><given-names>O.</given-names></name><name><surname>Han</surname><given-names>S. S.</given-names></name><name><surname>Sandoe</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>7</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.019</pub-id>
<pub-id pub-id-type="pmid">24703839</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Han</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Zhuang</surname><given-names>X.</given-names></name></person-group> (<year>2016a</year>). <article-title>Real-time imaging of translation on single mRNA transcripts in live cells.</article-title>
<source/><italic>Cell</italic>
<volume>165</volume>
<fpage>990</fpage>–<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.040</pub-id>
<pub-id pub-id-type="pmid">27153499</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>E. T.</given-names></name><name><surname>Taliaferro</surname><given-names>J. M.</given-names></name><name><surname>Lee</surname><given-names>J. A.</given-names></name><name><surname>Sudhakaran</surname><given-names>I. P.</given-names></name><name><surname>Rossoll</surname><given-names>W.</given-names></name><name><surname>Gross</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016b</year>). <article-title>Dysregulation of mRNA localization and translation in genetic disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>11418</fpage>–<lpage>11426</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2352-16.2016</pub-id>
<pub-id pub-id-type="pmid">27911744</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Siedlak</surname><given-names>S. L.</given-names></name><name><surname>Torres</surname><given-names>S.</given-names></name><name><surname>Fujioka</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mitofusin 2 regulates axonal transport of calpastatin to prevent neuromuscular synaptic elimination in skeletal muscles.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>28</volume>
<fpage>400</fpage>–<lpage>414.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2018.06.011</pub-id>
<pub-id pub-id-type="pmid">30017354</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Ilieva</surname><given-names>H.</given-names></name><name><surname>Tamada</surname><given-names>H.</given-names></name><name><surname>Nomura</surname><given-names>H.</given-names></name><name><surname>Komine</surname><given-names>O.</given-names></name><name><surname>Endo</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>8</volume>
<fpage>1421</fpage>–<lpage>1437</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201606403</pub-id>
<pub-id pub-id-type="pmid">27821430</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Westergard</surname><given-names>T.</given-names></name><name><surname>Krishnamurthy</surname><given-names>K.</given-names></name><name><surname>Markandaiah</surname><given-names>S. S.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Antisense proline-arginine RAN dipeptides linked to <italic>C9ORF72</italic>-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death.</article-title>
<source/><italic>Neuron</italic>
<volume>84</volume>
<fpage>1213</fpage>–<lpage>1225</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.010</pub-id>
<pub-id pub-id-type="pmid">25521377</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weskamp</surname><given-names>K.</given-names></name><name><surname>Tank</surname><given-names>E. M.</given-names></name><name><surname>Miguez</surname><given-names>R.</given-names></name><name><surname>Mcbride</surname><given-names>J. P.</given-names></name><name><surname>Gomez</surname><given-names>N. B.</given-names></name><name><surname>White</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>130</volume>
<fpage>1139</fpage>–<lpage>1155</lpage>. <pub-id pub-id-type="doi">10.1172/JCI130988</pub-id>
<pub-id pub-id-type="pmid">31714900</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westergard</surname><given-names>T.</given-names></name><name><surname>Jensen</surname><given-names>B. K.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>J.</given-names></name><name><surname>Kropf</surname><given-names>E.</given-names></name><name><surname>Iacovitti</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Cell-to-cell transmission of dipeptide repeat proteins linked to <italic>C9orf72</italic>-ALS/FTD.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>17</volume>
<fpage>645</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.032</pub-id>
<pub-id pub-id-type="pmid">27732842</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiedau-Pazos</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>J. J.</given-names></name><name><surname>Rabizadeh</surname><given-names>S.</given-names></name><name><surname>Gralla</surname><given-names>E. B.</given-names></name><name><surname>Roe</surname><given-names>J. A.</given-names></name><name><surname>Lee</surname><given-names>M. K.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Science</italic>
<volume>271</volume>
<fpage>515</fpage>–<lpage>518</lpage>. <pub-id pub-id-type="pmid">8560268</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>T. L.</given-names></name><name><surname>Cleveland</surname><given-names>D. W.</given-names></name></person-group> (<year>1999</year>). <article-title>Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>2</volume>
<fpage>50</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/4553</pub-id>
<pub-id pub-id-type="pmid">10195180</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>D. E.</given-names></name><name><surname>Van Niekerk</surname><given-names>E. A.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Mesngon</surname><given-names>M.</given-names></name><name><surname>Merianda</surname><given-names>T. T.</given-names></name><name><surname>Williams</surname><given-names>G. G.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Extracellular stimuli specifically regulate localized levels of individual neuronal mRNAs.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>178</volume>
<fpage>965</fpage>–<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200703209</pub-id>
<pub-id pub-id-type="pmid">17785519</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Eliscovich</surname><given-names>C.</given-names></name><name><surname>Yoon</surname><given-names>Y. J.</given-names></name><name><surname>Singer</surname><given-names>R. H.</given-names></name></person-group> (<year>2016a</year>). <article-title>Translation dynamics of single mRNAs in live cells and neurons.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>
<fpage>1430</fpage>–<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf1084</pub-id>
<pub-id pub-id-type="pmid">27313041</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C. H.</given-names></name><name><surname>Fallini</surname><given-names>C.</given-names></name><name><surname>Ticozzi</surname><given-names>N.</given-names></name><name><surname>Keagle</surname><given-names>P. J.</given-names></name><name><surname>Sapp</surname><given-names>P. C.</given-names></name><name><surname>Piotrowska</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2012b</year>). <article-title>Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nature</italic>
<volume>488</volume>
<fpage>499</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1038/nature11280</pub-id>
<pub-id pub-id-type="pmid">22801503</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J. W.</given-names></name><name><surname>Hussaini</surname><given-names>S. A.</given-names></name><name><surname>Bastille</surname><given-names>I. M.</given-names></name><name><surname>Rodriguez</surname><given-names>G. A.</given-names></name><name><surname>Mrejeru</surname><given-names>A.</given-names></name><name><surname>Rilett</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2016b</year>). <article-title>Neuronal activity enhances tau propagation and tau pathology in vivo.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>19</volume>
<fpage>1085</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4328</pub-id>
<pub-id pub-id-type="pmid">27322420</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Patterson</surname><given-names>B.</given-names></name><name><surname>Kang</surname><given-names>Y. J.</given-names></name><name><surname>Govindaiah</surname><given-names>G.</given-names></name><name><surname>Roselaar</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Fusion of regionally specified hPSC-derived organoids models human brain development and interneuron migration.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>21</volume>
<fpage>383</fpage>–<lpage>398.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2017.07.007</pub-id>
<pub-id pub-id-type="pmid">28757360</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Lin</surname><given-names>M. Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Foust</surname><given-names>K. D.</given-names></name><name><surname>Sheng</surname><given-names>Z. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Endolysosomal deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice.</article-title>
<source/><italic>Neuron</italic>
<volume>87</volume>
<fpage>355</fpage>–<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.06.026</pub-id>
<pub-id pub-id-type="pmid">26182418</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>L.</given-names></name><name><surname>Bassell</surname><given-names>G. J.</given-names></name></person-group> (<year>2013</year>). <article-title>mRNA localization: an orchestration of assembly, traffic and synthesis.</article-title>
<source/><italic>Traffic</italic>
<volume>14</volume>
<fpage>2</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1111/tra.12004</pub-id>
<pub-id pub-id-type="pmid">22913533</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Chun</surname><given-names>S. J.</given-names></name><name><surname>Boillee</surname><given-names>S.</given-names></name><name><surname>Fujimori-Tonou</surname><given-names>N.</given-names></name><name><surname>Yamashita</surname><given-names>H.</given-names></name><name><surname>Gutmann</surname><given-names>D. H.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>11</volume>
<fpage>251</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1038/nn2047</pub-id>
<pub-id pub-id-type="pmid">18246065</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Haertlein</surname><given-names>T. C.</given-names></name><name><surname>Carrasco</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>2</volume>
<fpage>799</fpage>–<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2012.08.025</pub-id>
<pub-id pub-id-type="pmid">23022481</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Hou</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Williams</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Atomic-resolution structure of the CAP-Gly domain of dynactin on polymeric microtubules determined by magic angle spinning NMR spectroscopy.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>14611</fpage>–<lpage>14616</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1509852112</pub-id>
<pub-id pub-id-type="pmid">26604305</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Hoek</surname><given-names>T. A.</given-names></name><name><surname>Vale</surname><given-names>R. D.</given-names></name><name><surname>Tanenbaum</surname><given-names>M. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Dynamics of translation of single mRNA molecules in vivo.</article-title>
<source/><italic>Cell</italic>
<volume>165</volume>
<fpage>976</fpage>–<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.034</pub-id>
<pub-id pub-id-type="pmid">27153498</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>Y. J.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Buxbaum</surname><given-names>A. R.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Tsai</surname><given-names>A.</given-names></name><name><surname>English</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Glutamate-induced RNA localization and translation in neurons.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>E6877</fpage>–<lpage>E6886</lpage>. <pub-id pub-id-type="pmid">27791158</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshizawa</surname><given-names>T.</given-names></name><name><surname>Ali</surname><given-names>R.</given-names></name><name><surname>Jiou</surname><given-names>J.</given-names></name><name><surname>Fung</surname><given-names>H. Y. J.</given-names></name><name><surname>Burke</surname><given-names>K. A.</given-names></name><name><surname>Kim</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites.</article-title>
<source/><italic>Cell</italic>
<volume>173</volume>
<fpage>693</fpage>–<lpage>705.e22</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.03.003</pub-id>
<pub-id pub-id-type="pmid">29677513</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C. L.</given-names></name><name><surname>Rodenkirch</surname><given-names>L.</given-names></name><name><surname>Schultz</surname><given-names>J. R.</given-names></name><name><surname>Chiu</surname><given-names>S. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>A novel method to study the local mitochondrial fusion in myelinated axons in vivo.</article-title>
<source/><italic>J. Neurosci. Methods</italic>
<volume>207</volume>
<fpage>51</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2012.03.013</pub-id>
<pub-id pub-id-type="pmid">22484559</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J. Q.</given-names></name><name><surname>Kelly</surname><given-names>T. K.</given-names></name><name><surname>Chang</surname><given-names>B.</given-names></name><name><surname>Ryazantsev</surname><given-names>S.</given-names></name><name><surname>Rajasekaran</surname><given-names>A. K.</given-names></name><name><surname>Martin</surname><given-names>K. C.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A functional role for intra-axonal protein synthesis during axonal regeneration from adult sensory neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>21</volume>
<fpage>9291</fpage>–<lpage>9303</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.21-23-09291.2001</pub-id>
<pub-id pub-id-type="pmid">11717363</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>M. Y.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>Z. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Facilitation of axon regeneration by enhancing mitochondrial transport and rescuing energy deficits.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>214</volume>
<fpage>103</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201605101</pub-id>
<pub-id pub-id-type="pmid">27268498</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zivraj</surname><given-names>K. H.</given-names></name><name><surname>Tung</surname><given-names>Y. C.</given-names></name><name><surname>Piper</surname><given-names>M.</given-names></name><name><surname>Gumy</surname><given-names>L.</given-names></name><name><surname>Fawcett</surname><given-names>J. W.</given-names></name><name><surname>Yeo</surname><given-names>G. S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Subcellular profiling reveals distinct and developmentally regulated repertoire of growth cone mRNAs.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>15464</fpage>–<lpage>15478</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1800-10.2010</pub-id>
<pub-id pub-id-type="pmid">21084603</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>